Lehto and Avara sign framework agreement formajor housing portfolio

The units are located at Kalasatama in Helsinki and in Kirkkonummi, Hämeenlinna, Kuopio and Oulu. The transaction price is more than EUR 53 million. Some of the units are already under construction and most of the units will be completed during 2019 and 2020. “It is exceptional to sell such a large number of units to one fund at one time,” says Hannu Lehto, CEO of the Lehto Group. “This portfolio includes excellent new construction in good locations. We are working with Lehto to build high-quality housing in cities with good residential investment potential,” says Mika Savolainen, CEO of Avara Oy. The financing for the construction will be arranged by Avara using both equity and loan. Lehto will build the units and sell them to the fund after completion and when other agreed requirements are met. This framework agreement has no impact on the outlook for 2018 previously published by the Lehto Group. Further information: Lehto Group PlcCEO Hannu Lehto+358 500 280 448hannu.lehto@lehto.fiwww.lehto.fi Avara OyCEO Mika Savolainen+358 400 986 526mika.savolainen@avara.fiwww.avara.fi Lehto is Finland’s fastest growing construction and real estate group. We operate in four service areas: Business Premises, Housing, Social Care and Educational Premises, and Building Renovation. We are an innovator and pioneer in the construction sector. Our economically driven operating model makes construction more profitable, ensures the quality of construction and brings significant time and cost savings to the customer. We employ around 1,300 people (Q1 2018), and our net sales for 2017 amounted to EUR 598 million. Avara is leading residential real estate investment and asset management company in Finland. We act as a valued, trustworthy and well-respected strategic partner for investors seeking to invest in residential real estate in Finland. At the moment we have 4 residential real estate portfolios under investment and asset management worth 1 billion euros. Avara Asuinkiinteistörahasto I Ky is a Finnish closed-end private equity fund that invests in residential real estate. The Fund's strategy is to acquire good cash flow and stable returns to investors through Avara's project development and construction company projects, as well as to respond to housing shortages in growth centers. The fund's investors are Finnish institutions and investment companies.

Sobi emphasises commitment to haemophilia community at WFH 2018 World Congress

Recent data show quality-of-life improvements for patients treated prophylactically with Elocta® and Alprolix®, extended half-life haemophilia therapies. Swedish Orphan Biovitrum AB (publ)  (Sobi™)(STO:SOBI) will present data at the World Federation of Hemophilia (WFH) 2018 World Congress, in Glasgow, Scotland, 20-24 May, demonstrating the company’s ongoing commitment to transforming the standard of care for people with haemophilia. Sobi will present real-world data demonstrating improvements in quality-of-life measures, including physical activity and joint pain, in patients treated prophylactically with Elocta (efmoroctocog alfa) for haemophilia A and Alprolix (eftrenonacog alfa) for haemophilia B, when compared with standard half-life factor treatments. Elocta and Alprolix are extended half-life haemophilia therapies with well-established safety and efficacy profiles and close to four years of real-world experience, supported by a growing body of real-world evidence from thousands of patients across all age groups. “We continue to advance our scientific understanding of our therapies’ impact on disease burden,” said Armin Reininger, Senior Vice President, Head of Medical and Scientific Affairs at Sobi. “By gathering data on outcomes such as physical activity and joint health status, we maintain our focus on research that reflects a meaningful difference for patients, providing protection beyond bleed prevention. The real-world data generated thus far support the safety profile of our products. Since both products are indicated for all age groups, in prophylaxis, on-demand as well as in surgery, they also provide the opportunity for individualised treatment.” Sobi will present a total of four abstracts including a joint presentation with Bioverativ Inc., a Sanofi company: Sobi presentations · Patient Reported Outcomes on Ways to Improve Haemophilia Care: Results from the CHESS Study: Wednesday, 23 May, 15:45-16:30. Poster #78 · The effect of switching to rFVIIIFc on treatment patterns and annualised bleed rate before and after: a within-patient comparison from the UK National Haemophilia Database: Wednesday, 23 May, 16:30-18:00. Oral presentation Do EHL products meet patients’ expectations (the HOPE study): Tuesday, 22 May, 16:30-18:00. Oral presentation Sobi and Bioverativ – joint presentation Economic impact of recombinant factor VIII Fc fusion protein (rFVIIIFc) compared to conventional factor VIII for immune tolerance induction (ITI) of Hemophilia A patients with inhibitors. Monday, 21 May, 16:30-18:00. Poster presentation #77 All oral and poster presentations can be accessed at the WFH 2018 World Congress website here.  In addition, Sobi and Bioverativ will co-host two scientific symposiums at the congress. · Advances in Haemophilia: Factor-Based Therapies and Long-Term Evidence versus New Treatment Modalities.  Monday, 21 May, 18:15 – 19:45, Hall 3, Scottish Event Campus. The session will be chaired by K. John Pasi, Professor, MD, PhD, Barts and the London School of Medicine and Dentistry, London and will be open to healthcare practitioners only. · Inhibitor Eradication: Clinician and Patient Perspectives on Safety Considerations and Long-Term Outcomes.  Tuesday, 22 May, 12:30-14:00, Hall 2, Scottish Event Campus. The session will be chaired by Victor Blanchette, MD, MA, MB, Pediatric Thrombosis and Hemostasis Program, The Hospital for Sick Children, Toronto and is open to all congress attendees. ----About Elocta®Elocta® (efmoroctocog alfa) is a recombinant clotting factor therapy developed for haemophilia A using Fc fusion technology to prolong circulation in the body. It is engineered by fusing factor VIII to the Fc portion of immunoglobulin G subclass 1, or IgG1 (a protein commonly found in the body), enabling Elocta to use a naturally occurring pathway to extend the time the therapy remains in the body (half-life). Elocta is manufactured using a human cell line in an environment free of animal and human additives. Elocta is approved and marketed by Sobi for the treatment of haemophilia A in the EU, Iceland, Kuwait, Liechtenstein, Norway, Saudi Arabia and Switzerland. It is approved and marketed as ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] by Bioverativ in the United States, Japan and Canada. It is also approved in Australia, New Zealand, Brazil and other countries, where Bioverativ has the marketing rights. As with any factor replacement therapy, allergic-type hypersensitivity reactions and development of inhibitors may occur in the treatment of haemophilia A. Inhibitor development has been observed with Elocta, including in previously untreated patients. For more information, please see the full U.S. prescribing information  for ELOCTATE. Note that the indication for previously untreated patients is not included in the EU Product Information  for Elocta.  About Alprolix®Alprolix® (eftrenonacog alfa), is a recombinant clotting factor therapy developed for haemophilia B using Fc fusion technology to prolong circulation in the body. It is engineered by fusing factor IX to the Fc portion of immunoglobulin G subclass 1, or IgG1 (a protein commonly found in the body), enabling Alprolix to use a naturally occurring pathway to extend the time the therapy remains in the body (half-life). Alprolix is manufactured using a human cell line in an environment free of animal and human additives.Alprolix is approved and marketed by Sobi for the treatment of haemophilia B in the EU, Iceland, Kuwait, Liechtenstein, Norway, Saudi Arabia and Switzerland, as well as in the United States, Canada, Japan, Australia, New Zealand, Brazil and other countries where Bioverativ has the marketing rights. Allergic-type hypersensitivity reactions and development of inhibitors have been observed with Alprolix in the treatment of haemophilia B, including in previously-untreated patients. For more information, please see the full U.S. prescribing information  for Alprolix. Note that the indication for previously-untreated patients is not included in the EU Product Information.  About haemophilia A and BHaemophilia is a rare, genetic disorder in which the ability of a person's blood to clot is impaired. Haemophilia A occurs in about one in 5,000 male births annually, and more rarely in females. Haemophilia B occurs in about one in 25,000 male births annually, and more rarely in females. The World Federation of Haemophilia estimates that approximately 180,000 people are currently diagnosed with haemophilia A and B worldwide.[i]  People with haemophilia A or B experience bleeding episodes that can cause pain, irreversible joint damage and life-threatening haemorrhages. Prophylactic infusions of factor VIII or IX can temporarily replace the clotting factors that are needed to control bleeding and prevent new bleeding episodes.[ii]  The World Federation of Hemophilia recommends prophylaxis as the optimal therapy as it can prevent bleedings and joint destruction.[iii]  About the Sobi and Bioverativ collaborationSobi and Bioverativ, a Sanofi company, collaborate on the development and commercialisation of Alprolix and Elocta/ELOCTATE. Sobi has final development and commercialisation rights in the Sobi territory (essentially Europe, North Africa, Russia and most Middle Eastern markets). Bioverativ has final development and commercialisation rights in North America and all other regions in the world excluding the Sobi territory, and has manufacturing responsibility for Elocta/ELOCTATE and Alprolix. While Fc fusion technology has been used for more than 15 years, Sobi and Bioverativ have optimised the technology and are the first companies to utilise it in the treatment of haemophilia. In 2014, Sobi added the rFVIIIFc-XTEN-vWF fusion molecule for potential treatment of haemophilia A, to the collaboration agreement.  About Sobi™Sobi™ is an international speciality healthcare company dedicated to rare diseases. Our vision is to be recognised as a global leader in providing access to innovative treatments that make a significant difference for individuals with rare diseases. The product portfolio is primarily focused on treatments in Haemophilia and Specialty Care. Partnering in the development and commercialisation of products in specialty care is a key element of our strategy. Sobi has pioneered in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In 2017, Sobi had total revenues of SEK 6.5 billion and approximately 850 employees. The share (STO:SOBI) is listed on Nasdaq Stockholm. More information is available at www.sobi.com.  For more information please contact Media relations Sobi Investor relations SobiLinda Holmström, Senior Jörgen Winroth, ViceCommunications Manager President, Head of Investor Relations+46 70 873 40 95 +1 347 224 0819, +1 212 579 0506linda.holmstrom@sobi.com  jorgen.winroth@sobi.com  ---------------------------------------------------------------------- [i]  World Federation of Hemophilia. Annual Global Survey 2015, published in October 2016. Available at: http://www1.wfh.org/publication/files/pdf-1669.pdf . Accessed on May 23, 2017. [ii]  World Federation of Hemophilia. About Bleeding Disorders – Frequently Asked Questions. Available at: http://www.wfh.org/en/page.aspx?pid=637 . Accessed on May 23, 2017. [iii]  World Federation of Hemophilia. Guideline for the management of hemophilia, 2nd edition. Available at: http://www1.wfh.org/publication/files/pdf-1472.pdf . Accessed on May 23, 2017.

Finnair CEO Pekka Vauramo leaves the company to join Metso Corporation

Finnair Plc         Stock Exchange Release        21 May 2018        at 8.30 a.m. EET Finnair’s CEO, Pekka Vauramo, has given notice of his resignation from the company to join Metso Corporation as their new CEO. He will leave Finnair at the latest in November 2018. The search for Vauramo’s successor starts today. “The Board of Finnair is naturally sad to see Pekka Vauramo leave the company, but we also respect his personal decision to take on another challenge. We thank Pekka for his leadership in the past five years and wish him lots of success in his future role,” says Jouko Karvinen, chairman of Finnair’s board of directors. “During the past few years, Finnair’s people have achieved a remarkable transformation and have turned Finnair into a growth company. We all at Finnair, including the board, will now continue this extensive journey of transformation.” “We have been through a lot at Finnair over the past five years,” says Pekka Vauramo, Finnair’s CEO. “Our strategic focus on growth, customer experience, personnel experience and transformation has been the right choice, and I want to extend my warm thanks to the entire Finnair team for this. I have now been offered to take on one more challenge, and this has not been an easy decision for me to make. I am grateful for having been a part of this change journey, and I am committed to leading Finnair together with my team for the rest of my time at Finnair. Our company’s focus needs to be on the future development of the company every day.”

SaltX receives SunCool breakthrough order

SaltX communicated at the renewable energy conference Ghana in October of last year that it had initiated a collaboration with the energy company SunAct (previously SolarX). SunAct has already purchased a small number of SunCool collectors that are now being installed for demonstration purposes at the institute of industrialization, CSIIR in Accra.  ”This order is important for us on several levels; it accelerates sales in Africa - a key market for SunCool outside of China, and it proves the strength of SunCool as an autonomous and cost efficient solar energy solution. It is also important to show that our technology can make a big difference for many people who today lack basic pre-requisites”,says Karl Bohman, CEO of SaltX Technology. SunAct’s customer – Thermodul Systems – is a German house manufacturer with unique and cost-effective module-based building technology. The company recently signed a $300-million contract with Ghana First that will operate the stations on behalf of Ghana’s government.  ”We are pleased to have SaltX as partner in this important endeavor offering sustainable energy to autonomous sanitation buildings in Ghana. Our ambition is to become Ghana’s leading provider of solar energy solutions, and with our strong collaboration with CSIIR we can access 1,400 installers to implement solar energy systems including SunCool”, says Francis Asante, CEO of SunAct. SunAct is to import SunCool collectors from SaltX and its Chinese partner NSECT but has an option to, after the first 1,000 collectors have been delivered, purchase the core tubes with SaltX material from NSECT, still via SaltX, and then assemble the collectors in Ghana. Om SunActSunAct is a private, newly started energy company in Ghana with the ambition to deliver, install and operate innovative and cost efficient solar energy solutions. The company obtains in connection with this SunCool order an exclusive market right to, during the term of the contract, sell SunCool in Ghana. Om ThermodulThermodul Systems - http://www.thermodulsystem.de– is a manufacturer of a unique and inexpensive module-based building technology that makes it possible to construct buildings in significantly less time than conventional technologies and/or material.   Om SaltX TechnologySaltX Technology - www.saltxtechnology.com- develops and sells patented energy storage technology. Main customers are major global OEM partners and energy companies such as Alfa Laval, Vattenfall, Mobile Climate Control and Rheem. SaltX Technology's share is listed on NASDAQ First North Premier in Stockholm. SaltX Technology’s Certified Adviser is FNCA Sweden AB. For further information, please contact: Karl Bohman, CEO SaltX Technology, tel: +46-705 600 268 ************************************************** SaltX Technology is obliged to disclose this information under the EU Market Abuse Regulation (MAR). The information was provided by the contact person listed above, for publication on May 21, 2018, at 8 am CET.   StockholmMay 21, 2018

KARO PHARMA RECEIVES MILESTONE PAYMENT FOR RORGAMMA PROJECT FROM PFIZER

Pfizer has informed Karo Pharma that a new milestone has been achieved. This means that Karo Pharma receives a payment of 6 MUSD. In December 2011, Karo Pharma entered a research collaboration and licensing agreement with the American company Pfizer. The aim of this agreement is to discover and develop compounds that inhibit the activity of the nuclear hormone receptor RORgamma, for treatment of autoimmune diseases. The development is lead by Pfizer according to the terms of the agreement. Pfizer has global exclusive rights to use, develop, manufacture and commercialize the compounds and products developed under the agreement, and holds patents relating to the compounds and products developed. Karo Pharma can receive up to 200 MUSD when Pfizer achieves certain development and sales milestones in the project. In addition, Karo Pharma is entitled to royalties on future sales. "We are very pleased to receive this milestone and that the project is moving forward successfully” says Anders Lönner, Chairman of the Board, Karo Pharma.ABOUT KARO PHARMAKaro Pharma is a specialty pharma company that develops and markets products to pharmacies and directly to healthcare providers. The share is listed on Nasdaq Stockholm in the Mid Cap segment. The information in this report is such that Karo Pharma is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication on May 21, 2018 at 08.00 CET. This press release is also available on www.newsroom.cision.com.FORWARD-LOOKING STATEMENTSThis news release contains certain forward-looking statements that are based on uncertainty, as they relate to events and depend on circumstances that will occur in the future and which, by their nature, may have an impact on results of operations and the financial condition of Karo Pharma. Such forward-looking statements reflect our current expectations and are based on the information currently available. Karo Pharma cannot give any assurance as to whether such forward-looking statements will prove to be correct. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.

Obducat receives order from customer in Germany

The QS W 775 Developer System, to be used for resist development and stripping, will be installed in the cleanroom facilities in customers’ manufacturing department. The customer already has several lithography processing systems from Obducat Europe GmbH. No further information can be disclosed at this time. Delivery of the QS W 775 Developer System is planned for in the fourth quarter 2018.   This is information that Obducat AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, on May 21st, 2018 at 08.15 CET. For further information contact: Patrik Lundström, CEO: +46 46 10 16 00 or +46 703 27 37 38 Björn Segerblom, Chairman of the Board:  + 46 (0) 46-10 16 00 or +46 (0) 852 6071 2250   About Obducat AB (publ) Obducat AB (publ) is an innovative developer and supplier of technologies, products and processes used for the production and replication of advanced micro and nano structures. Obducat’s products and services serve the demands of companies within the LED, OLED, semiconductor, displays, biomedical and MEMS industries. Obducat’s technologies include nano imprint technology, coating technology and wet processing technology. Obducat has offices in Sweden, Germany and China and the headquarter is located in Lund, Sweden. Obducat’s class B shares and preferential class B shares are publicly traded on the Swedish NGM Equity stock exchange. Read more at www.obducat.com.

NOTICE OF THE ANNUAL GENERAL MEETING FOR REALFICTION HOLDING AB (publ) AND PUBLICATION OF ANNUAL REPORT FOR 2017

RIGHT TO PARTICIPATE Those wishing to attend the General Meeting must - be registered as shareholders in the share register maintained by Euroclear Sweden AB as of Tuesday, June 12, 2018, - notify the Company of their intention to attend no later than Tuesday, June 12, 2018. NOTIFICATION TO THE COMPANY Registration of participation shall be provided by email to: investor@realfiction.com. Registration may also be provided in writing to Realfiction Holding AB, Terminalgatan 1, 252 78 Helsingborg. When registering, shareholders are asked to state their name or business name, personal ID or company registration number, number of shares held, address, daytime telephone number and, if applicable, information about deputies or advisors (maximum two). PROXY AND PROXY FORM Shareholders not attending the General Meeting in person may exercise their rights at the AGM by proxy, by providing a written, signed and dated proxy (original). Proxies must not be more than one year old unless a longer period of validity, not exceeding five years, is stated in the proxy.  If a proxy is issued by a legal entity, a copy of the entity’s registration document or similar authorisation document must be attached. A proxy form is available at the Company’s website, www.realfiction.com. The proxy form can also be obtained from the Company by e-mail as above. To facilitate entry into the General Meeting, proxies, registration documents and other authorisation documents should be provided to the Company in connection with the registration of participation, i.e. in advance of the General Meeting. To have the right to attend the General Meeting, shareholders whose shares are registered with a nominee must have their shares re-registered in their own name in the share register maintained by Euroclear Sweden AB well ahead of 12 June 2018. The re-registration may be temporary. The registration must be completed no later than 12 June 2018. Information retrieved from the share register maintained by Euroclear Sweden AB, registrations of participation along with information about proxies, deputies and advisors will be used for the registration procedure, preparation of the voting list and, if applicable, for the Minutes from the AGM. PROPOSED AGENDA FOR THE GENERAL MEETING 1. Election of chairman for the General Meeting 2. Preparation and approval of the voting list 3. Approval of the agenda 4. Election of one or two persons to verify the minutes 5. Determination of whether the General Meeting was duly convened 6. Presentation of the annual report and the auditor’s report as well as the consolidated financial statements and auditor’s report for the Group 7. Resolutions on a) adoption of the income statement and balance sheet as well as the consolidated income statement and consolidated balance sheet b) appropriation of the Company’s earnings according to the adopted balance sheet c) discharging the members of the Board of Directors and the CEO from liability vis-à-vis the Company 8. Resolution on fees payable to the Board members and the auditor 9. Election of Board members, Chairman of the Board and auditor 10. Resolution on authorization for the board of directors regarding new issues                     11. A.O.B. to come before the Meeting in accordance with the Company’s Articles of Association or the Companies Act 12. Conclusion of the General Meeting After the conclusion of the AGM, the Company’s Management will give a presentation of Realfiction and its operations. In connection therewith, attending shareholders will have the opportunity to ask questions. PROPOSALS ELECTION OF CHAIRMAN FOR THE GENERAL MEETING (Item 1) The Nomination Committee proposes that Åsa Hansdotter be elected as chairman of the meeting. RESOLUTIONS ON APPROPRIATION OF THE COMPANY’S EARNINGS ACCORDING TO THE ADOPTED BALANCE SHEET (Item 7 b) The Board of Directors and the CEO propose that no dividend be paid to the shareholders for the financial year 2017, and that the loss for the year be carried forward. RESOLUTION ON FEES PAYABLE TO THE BOARD MEMBERS AND THE AUDITOR (Item 8) The Nomination Committee proposes that fees paid to the Board members shall amount to DKR 75.000 per year and for the Chairman of the Board DKR 150.000 per year. Fees are only payable to Board members not employed by the Company. The Nomination Committee furthermore proposes that fees to the auditor be paid in accordance with approved invoices. ELECTION OF BOARD MEMBERS, CHAIRMAN OF THE BOARD AND AUDITOR (Item 9) The Nomination Committee proposes the re-election of Board members Søren Jonas Bruun, Peter Max, Clas Dyrholm and Peter Simonsen as well as the election of Peter Bugge Johansen as a new board member. It is furthermore proposed that Michael Kjær be re-elected as Chairman of the Board. Finally, the Nomination Committee proposes the re-election of the registered accountancy firm Mazars SET Revisionsbyrå AB, who has notified that Bengt Ekenberg will remain chief auditor. RESOLUTION ON AUTHORIZATION FOR THE BOARD OF DIRECTORS REGARDING NEW ISSUES (Item 10) The board of directors proposes that the annual general meeting resolves to authorize the board of directors to, at one or several occasions, during the time up until the next annual general meeting, with or without deviation from the shareholders’ preferential rights, resolve to issue shares and/or convertibles. A new issue should be able to be made with or without provisions regarding contribution in kind, set-off or other conditions. In case the authorization is used for a new issue of shares, the total number of shares that may be issued shall not exceed 1 744 970 shares, corresponding to 15 percent of the total number of existing shares in the company at the time of the annual general meeting and the subscription price shall be on market terms (subject to customary new issue discount, as applicable). The purpose of the authorization as regards new issues of shares is to be able to source working capital, to be able to execute and finance acquisitions of companies as well as to enable new issues to industrial partners within the framework of partnerships and alliances. Upon full utilization of the authorization, a maximum of 1 744 970 shares will be issued or alternatively be issued upon conversion, which corresponds to a total dilution effect of approximately 13 percent. The company’s CEO shall be authorized to make such minor formal adjustments of the resolution as might be necessary in connection with registration with the Swedish Companies Registration Office. ANY OTHER BUSINESS TO COME BEFORE THE MEETING IN ACCORDANCE WITH THE COMPANY’S ARTICLES OF ASSOCIATION OR THE COMPANIES ACT (Item 11) As of the date of publication of this notice, no such business has been submitted to the Company.   DOCUMENTS The Company’s Annual Report for the accounting year 2017, the auditor’s report for the same period and the proxy form for the AGM will be available on the Company’s website (www.realfiction.com) no later than 28 May. All documents will also be available at the Company, Terminalgatan 1, C/O Mazars SET Revisionsbyrå AB in Helsingborg, and will be sent to the shareholders who so request and provide their postal address. The documents will also be available at the AGM.  NUMBER OF SHARES AND VOTES The total number of shares and votes in the Company as of the issue date for the notice is 11 633 135. As of the same date, the Company is holding no shares in treasury. INFORMATION AT THE AGM The Board of Directors and the CEO must, at the request of any of the shareholders and if the Board deems it possible without causing material harm to the Company, provide information at the General Meeting on circumstances that may impact the assessment of an item on the agenda, circumstances that may impact the assessment of the Company’s or a subsidiary’s financial situation, the consolidated financial statements and the Company’s relationship with other Group companies. Shareholders wishing to submit questions in advance may do so to the Company’s email address: investor@realfiction.com. Helsingborg, May 2018 The Board of Directors of Realfiction Holding AB (publ) For more information about Realfiction Holding AB, please contact:  Clas Dyrholm, founder and CEO  Telephone: +45 25 22 32 81  Email: clas@realfiction.com   www.realfiction.com    Certified Adviser   Sedermera Fondkommission is the company's Certified Adviser. This information is information that Realfiction Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on May 21st, 2018.  About Realfiction Holding AB Founded in Denmark in 2008, Realfiction is a leading mixed-reality solutions company, a market estimated to reach USD 80 billion by 2025. The company’s first product, Dreamoc, has been sold in over 10.000 units. DeepFrame, a new patent-pending product platform available as mixed-reality displays in larger and smaller formats, was made available to customers in September 2017. DeepFrame enables a wide range of new application areas for companies within entertainment, manufacturing and retail. The platform is also being developed for innovative consumer products. For easy access to Realfiction’s products, the company provides complete solutions that can be purchased, rented or leased in collaboration with a global network of distributors and content creators. Realfiction Holding AB’s share is publicly traded on Nasdaq Stockholm First North under the symbol “REALFI”. The share’s ISIN code is SE0009920994.

Net Gaming completes acquisition of assets in the DACH region

On April 19, 2018, Net Gaming announced the signing of a Letter of Intent to this effect. Net Gaming has now signed an agreement to acquire these affiliate assets.The operations show strong growth and are currently generating quarterly sales of approximately EUR 200,000, with an operating margin of approximately 75%. About 75% of the revenues are generated via revenue sharing. “The acquisition strengthens our position in the DACH region. We have identified the DACH region as one of the geographical markets with the highest growth potential in the long run. This transaction will give us further opportunities to grow our existing operations in the region, and also expand these assets to new markets. Considering the fact the the founders will remain and continue to work with the assets for Net Gaming feels truly great, since we have got a great first impression of the said founders,” comments Marcus Teilman, CEO of Net Gaming. "We are truly excited at finding the right buyer for our business, and are looking forward to work with the team at Net Gaming to take the websites to the next level. With its proven track record and a group of savvy people around, Net Gaming takes a great leap forward to become a major player in performance marketing on the DACH market." comments André Boeck, founder and CEO of Webwiser. The initial purchase consideration of EUR 2.29 million will be settled with existing cash resources. Payment of a maximum aditional consideration of EUR 1.25 million may also be required. The acquired assets from Webwiser will be consolidated immediately and will have a positive impact of Net Gaming's profit. For further information, please contact:Marcus Teilman, President and CEO+356 9936 7352 Net Gaming Europe AB (publ)                 Telephone: +46 8-410 380 44E-mail: info@netgaming.seWebsite: www.netgaming.se The information in this press release is information that Net Gaming Europe AB (publ) is required to disclose in accordance with the EU Market Abuse Regulation and, where applicable, the Swedish Securities Market Act and/or the Swedish Financial Instruments Trading Act. The information was provided by the contact person above for publication on 21 May 2018 at 08.30 CET.  About Net Gaming Net Gaming owns, operates and develops high-quality online comparison sites for the purpose of channelling user traffic to the Company’s customers – primarily iGaming operators. Within the Group, approximately 130 comparison sites are operated in 30 countries. Net Gaming generates valuable user traffic through the sites, mainly to global iGaming operators. The Company was founded in 2005, has over 80 employees and is headquartered in Malta. The share (NETG) is listed on AktieTorget.

Cantargia receives Notice of Allowance from USPTO for the antibody CAN03

Cantargia develops antibody based pharmaceuticals against the interleukin 1 receptor accessory protein (IL1RAP). The lead project CAN04 is currently in clinical development for treatment of non-small cell lung cancer and pancreatic cancer. A second project, CANxx, is in preclinical phase with the aim to develop an antibody against IL1RAP for treatment of autoimmune/inflammatory diseases. One antibody, CAN03, originally developed as a backup candidate for CAN04, modifies IL1RAP signaling in a unique way and has additionally demonstrated interesting IL-33 blocking properties. CAN03 is included in the CANxx discovery program. The USPTO has now notified Cantargia that a notice of allowance for Cantargia’s patent application 15/501,710 has been issued. This patent application includes the antibody CAN03. In essence, this means that the USPTO intends to grant the patent after certain formal steps has been completed. If granted, the patent is valid until 2035. “We are very pleased that the USPTO intends to grant a patent for our antibody CAN03. This antibody has unique properties in that it blocks signaling from both IL-1 and IL-33, a combination that may be highly relevant for the treatment of inflammatory and autoimmune diseases. This patent application is an important component of the IP portfolio around our CANxx project”, Göran Forsberg, Cantargia’s CEO says. For further information, please contact Göran Forsberg, CEOTelephone: +46 (0)46-275 62 60E-mail: goran.forsberg@cantargia.com This constitutes information that Cantargia AB is required to publish under the EU’s Market Abuse Regulation. The information was submitted for publication through the above contact person on 21 May 2018, at 8:30 a.m. About Cantargia Cantargia AB (publ), reg.no. 556791-6019, is a biotech company that is developing antibody-based treatments for life-threatening diseases. The original discovery by the research team behind Cantargia was the overexpression of a specific target molecule, interleukin 1 receptor accessory protein (IL1RAP) in leukemic stem cells. Subsequent research has also identified IL1RAP in many other forms of cancer. The company’s main project, the CAN04 antibody targeted at IL1RAP, is being studied in the CANFOUR clinical phase I/IIa study, where the primary focus is on non-small cell lung cancer and pancreatic cancer. CAN04 has two modes of action: it blocks the function of IL1RAP and stimulates the immune system to destroy tumour cells. Cantargia’s second project, currently in the research phase, is aimed at developing an IL1RAP-binding antibody that is optimised for treatment of autoimmune and inflammatory diseases. Cantargia is listed on Nasdaq Stockholm First North (ticker: CANTA). Sedermera Fondkommission is the company’s Certified Adviser. More information about Cantargia is available at http://www.cantargia.com.

St1 and SCA form partnership to produce renewable fuels

The aim of the partnership is to construct a new facility to produce advanced renewable fuels from tall oil with a capacity of 100 000 tonnes per annum. Construction of the new facility, subject to permission process and final approval from both companies, is expected to cost around 500 MSEK to build and is planned to be operational in 2021. Tall oil is a residual product from the production of kraft pulp in SCA’s mills Östrand, Obbola and Munksund. SCA is presently expanding its kraft pulp mill Östrand and as a result the production of tall oil from the mill will increase by more than 100 per cent. Between the two partners, the parties constitute the full value-chain from the raw material to the refining process, distribution and sale of the renewable fuel to the customers. "Partnership with SCA is a key element in implementation of our renewable fuels investment program and it secures supply of raw materials to meet the ambitious Nordic climate targets for 2030," says Mika Anttonen, Chairman of the Board of St1. “SCA works with a number of interesting development projects in renewable energy, and we see interesting opportunities to further develop the cooperation.” "When we start working on more refined energy products, partnership with a company that knows the processes and the market, is very valuable," says Ulf Larsson, President and CEO of SCA. “St1 is a company with the ambition to work with us in the change towards renewable fuels.” For further information, please contact Björn Lyngfelt, SVP Communications SCA, tel. +46 60 19 34 98Mikael Källgren, President Renewable Energy SCA, tel. +46 60 19 33 17Bo-Erik Svensson, CEO St1 Refinery, tel. +46 31 744 6250, bo-erik.svensson@st1.se  St1 Nordic Oy is a Nordic energy group whose vision is to be the leading producer and seller of CO2-aware energy. The Group researches and develops economically viable, environmentally sustainable energy solutions. St1 focuses on fuels marketing activities, oil refining and renewable energy solutions such as waste-based advanced ethanol fuels and industrial wind power. The Group has 1400 St1 and Shell branded retail stations in Finland, Sweden and Norway. Headquartered in Helsinki, St1 employs currently more than 750 people. www.st1.eu  The core of SCA’s business is the forest, 2.6 million hectares in northern Sweden. Around this unique resource, we have built a well-developed value chain based on renewable raw material from our own and others’ forests. We offer paper for packaging and print, pulp, wood products, renewable energy, services for forest owners and efficient transport solutions. 2017 the forest products company Svenska Cellulosa Aktiebolaget SCA (publ) had approximately 4,000 employees and sales amounted to approximately SEK 16.7 bn (EUR 1,6 bn). SCA was founded in 1929 and has its headquarters in Sundsvall, Sweden. More information at www.sca.com.

Ericsson Expert Analytics selected by EE to improve customer experience

Ericsson (NASDAQ: ERIC) has been selected by EE, the UK’s largest mobile operator and part of the BT Group, to deliver a next-generation customer experience management (CEM) system based on Ericsson Expert Analytics . The multi-year agreement includes software, implementation services and IT Managed Support services. The solution will support multiple services, including 2G, 3G, 4G, VoLTE and VoWiFi, and is aimed at improving subscriber satisfaction, net promoter score, propensity to call and first call resolution rate. Dave Salam, EE Director of Mobility and Analytics, says: “With Ericsson Expert Analytics supporting our new customer experience management capability, we will be better able to understand our customers’ experience in real-time, and the detailed insights provided will help us keep improving network quality.” Arun Bansal, Senior Vice President and Head of Market Area Europe and Latin America, Ericsson, says: “This is another significant milestone in our relationship with EE and an important deal for us in the field of IT. The introduction of Ericsson Expert Analytics will enable more effective customer care and service operations, allowing EE to proactively resolve issues before they have an impact on subscriber satisfaction.” Ericsson Expert Analytics will measure the perceived customer experience for each subscriber, providing actionable insights based on data collected in real-time from network elements and probes, as well as from operations and business support systems. NOTES TO EDITORS For media kits, backgrounders and high-resolution photos, please visit www.ericsson.com/press FOLLOW US: www.twitter.com/ericssonwww.facebook.com/ericssonwww.linkedin.com/company/ericssonwww.youtube.com/ericsson Subscribe to Ericsson press releases here . MORE INFORMATION AT: News Center  media.relations@ericsson.com(+46 10 719 69 92) investor.relations@ericsson.com(+46 10 719 00 00) ABOUT ERICSSON Ericsson enables communications service providers to capture the full value of connectivity. The company’s portfolio spans Networks, Digital Services, Managed Services, and Emerging Business and is designed to help our customers go digital, increase efficiency and find new revenue streams. Ericsson’s investments in innovation have delivered the benefits of telephony and mobile broadband to billions of people around the world. The Ericsson stock is listed on Nasdaq Stockholm and on Nasdaq New York. www.ericsson.com ABOUT EE EE, part of BT Group, is the largest and most advanced mobile communications company in the UK, delivering mobile and fixed communications services to consumers. EE runs the UK's biggest and fastest mobile network, offering superfast 4G in more places than any other operator after pioneering the UK's first superfast 4G mobile service in October 2012. Today, EE has more than 600 shops across the UK, and EE's 4G coverage extends to more than 90% of the UK’s landmass. EE has received extensive independent recognition, including being ranked the UK's best overall network by RootMetrics®; Best Network for five years in a row at the Mobile Choice Awards; Best Network at the 2015, 2016 and 2017 Mobile News Awards; Best Consumer Network at the 2015, 2016 and 2017 Mobile Industry Awards; as well as Fastest Network and Best Network Coverage at the 2017 uSwitch Mobile Awards. Find us: Facebook at: facebook.com/ee Twitter at: twitter.com/ee YouTube at: youtube.com/ee 

Siemens partners with Clean Motion to enable innovative digitalization journey

Siemens announced today a new partnership with Clean Motion AB, manufacturer of the electric vehicle Zbee, which will help enable Clean Motion to build and maintain a digital master factory using Siemens’ technology and solutions. Clean Motion has a global expansion strategy based on distributed local manufacturing in many smaller factories close to the end customer. To succeed in such an expansion, it is important to ensure a digitally defined product and manufacturing process together with a centrally controlled supply chain. Clean Motion is now taking the next step in its digitalization process with Siemens PLM Software to reach fully digital twins of both the product, the manufacturing process and the factory. As part of the digitalization strategy, a digital master factory will be built with Siemens’ product lifecycle management (PLM) software. This factory will then allow adjustments for the introduction of new variants and optimization of production flows. Clean Motion will be able to build a large number of independent physical plants and help ensure they operate in exactly the same way worldwide, by using Siemens PLM Software solutions that will maintain and manage the digital twin mirroring the Clean Motion digital master factory. Clean Motion plans to deploy Mindsphere, the cloud-based open Internet of Things (IoT) operating system from Siemens, powered by Amazon Web Services (AWS), to enable the connected factory and create a closed loop process that monitors and feeds back live data from usage and factory to further optimize Clean Motion’s business and process. "The use of Siemens’ solutions for IoT will provide opportunities to record how the product is produced and used in real time,” said Göran Folkesson, CEO of Clean Motion. “With this information we can optimize our existing business model but also develop new business opportunities. This also means that we will be able to return information about usage and manufacturing, ensuring that we are constantly building with the same high quality throughout the world.” Clean Motion’s business model is based on a central purchasing and logistics organization with local production units building, servicing and providing Zbee on the local market. The goal is that each micro factory will have an annual capacity of approximately 5,000 vehicles. The concept is based on the fact that each micro factory contains all parts for the entire vehicle's life cycle, where production, sales and aftermarket are aggregated. Clean Motion will make use of Siemens’ NX™ software, a leading integrated solution for computer-aided design, manufacturing and engineering (CAD/CAM/CAE), the Teamcenter®portfolio, the world’s most widely used digital lifecycle management software, the Simcenter™ portfolio, a robust suite of simulation software and test solutions, and the Tecnomatix®portfolio, the industry-leading digital manufacturing software solutions to build and maintain the digital twin. Clean Motion will also use Siemens’ Managed Services with Teamcenter on the cloud, powered by AWS, with a goal to have an end-to-end industrial software solution on the cloud. "We will create a closed system with a network of centrally controlled production units. This would not have been possible without a partner like Siemens," said Niklas Ankarkrona, chairman, Clean Motion. "Clean Motion’s business model provides a solid base for their digitalization journey, and our software provided as a hosted cloud service on AWS can give the end-to-end solution necessary for their critical next steps,” said Mats Friberg, CEO, Siemens PLM Software, Sweden. “Collaborating with companies such as Clean Motion allows Siemens to achieve a high level of innovation and realization of these new technologies in combination with already developed working methods.” The collaboration will not be limited to the factory. Zbee is already building a virtual product, and with the Siemens PLM software portfolio, Clean Motion will build a digital twin of the product, process and factory, enabling even greater opportunities to simulate, optimize and verify both product and production. Using the digital twin, Clean Motion will be able to simulate the vehicle's entire life cycle before it is completed. For further information on the digital twin and Siemens’ PLM portfolio, please see https://www.plm.automation.siemens.com/global/en/. Siemens PLM Software, a business unit of the Siemens Digital Factory Division, is a leading global provider of software solutions to drive the digital transformation of industry, creating new opportunities for manufacturers to realize innovation. With headquarters in Plano, Texas, and over 140,000 customers worldwide, Siemens PLM Software works with companies of all sizes to transform the way ideas come to life, the way products are realized, and the way products and assets in operation are used and understood. For more information on Siemens PLM Software products and services, visit www.siemens.com/plm. Contact for journalists Natalie NavalesPhone: +1 314 264 8671;E-mail: Natalie.Navales@siemens.com Johan NybomPhone: +46 73 660 81 75E-mail: Johan.Nybom@inmema.com Follow us on Twitter at: www.twitter.com/siemens_press Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for 170 years. The company is active around the globe, focusing on the areas of electrification, automation and digitalization. One of the world’s largest producers of energy-efficient, resource-saving technologies, Siemens is a leading supplier of efficient power generation and power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. The company is also a leading provider of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2017, which ended on September 30, 2017, Siemens generated revenue of €83.0 billion and net income of €6.2 billion. At the end of September 2017, the company had around 377,000 employees worldwide. Further information is available on the Internet at www.siemens.com. Note: Siemens, the Siemens logo and Simatic IT are trademarks or registered trademarks of Siemens AG. Teamcenter, NX and Tecnomatix are trademarks or registered trademarks of Siemens Product Lifecycle Management Software Inc. or its subsidiaries in the United States and in other countries. Simcenter is a trademark or registered trademark of Siemens Industry Software NV or any of its affiliates. All other trademarks, registered trademarks or service marks belong to their respective holders.

Mr Green and Gamingzone establish a joint venture for esports

Mr Green  and Gamingzone Entertainment have established a joint venture to create a new community for esports fans with focus on entertainment, news and gaming possibilities. Mr Green runs several iGaming sites, such as Mr Green  and Redbet . Gamingzone Entertainment is specialised in esports and gaming entertainment. The new joint venture will have a new, not yet decided, brand. The joint venture is owned to 55 per cent by Mr Green and to 45 per cent by Gamingzone Entertainment. Karl Mikael Cakste, one of the founders of Gamingzone, has initially been appointed CEO. ”Esports is a quickly growing, global phenomena and an increasing number of fans is spending time on gaming as well as different kind of videos. Experts believe this can become as huge as traditional sports. We want to be part of this development and create a presence among all its fans. In Gamingzone, we have found a partner who understands esports, content and entertainment”, says Per Norman, CEO of Mr Green. Gamingzone Entertainment was founded in 2017 by individuals with long backgrounds from the media and entertainment industry and companies such as MTG, TV4, Zodiak and Endemol Shine. The company has created the reality show GAMERZ where future talents within the game Counterstrike Global Offensive get the opportunity to become esports professionals. ”Entertainment and betting within esports is still immature. We are convinced that there are interesting and entertaining ways of offering the fans something better than what we have seen so far”, says Karl Mikael Cakste. “We are happy to partner with Mr Green which is an established, knowledgeable iGaming company that acts responsibly and is long-term.” ”Our main ambition is to create a community where esports fans from the entire world love to spend time. People of the age of 18 and older who wants to bet will in due time be offered that opportunity under just and safe conditions”, concludes Cakste. The new esports community will launch during the fall 2018. The rational for the new venture will be presented at Mr Green’s Capital Markets Day 23 May 01:00p.m.−05:00p.m. CET in Epicenter, Stockholm. To register . The Capital Markets Day is webcasted live at mrg.se  and financialhearings.com . For further information, please contact:Per Norman, CEO of Mr Green & Co AB, tel. +46 (0) 722 30 9191, per.norman@mrg.se Åse Lindskog, Communication and IR, tel. +46 (0) 730 24 48 72, ase.lindskog@mrg.se Karl Mikael Cakste, CEO of Gamingzone Entertainment, tel. +46 (0) 70 778 87 87, kmc@gze.global Mr Green is a leading online gaming company with operations in twelve countries. The business concept is to offer entertainment and a first-class gaming experience in a responsible environment. The business was founded in 2007 and has developed into a well-established online gaming company with a broad customer offer and a strong globally viable brand. In 2017, Mr Green generated sales of SEK 1,192.0 million and the company has over 300 employees. The headquarters and technical development are based in Stockholm, and operations in Malta. Mr Green has gaming licenses in Malta, UK, Italy, casino license in Denmark and Sportsbook license in Ireland. The company is listed on Nasdaq Stockholm’s Mid Cap segment. Read more at www.mrg.se.  Gamingzone Entertainment is an entertainment company in esports focused on creating narrative and entertaining original e-sports content. The founders have a background from TV4, MTG and Endemol Shine and have been involved in productions of Big Brother, Idol, Survivor, Deal or no deal and more. Read more at www.gze.se.  

NeuroVive and Yungjin reports positive KL1333 phase I clinical study results paving the way for further clinical development

Review of the topline phase I data shows that KL1333 has a highly favourable and very clear dose-proportional pharmacokinetic (PK) profile. There were no serious adverse events (SAEs), and only mild gastrointestinal adverse events (AEs) were recorded at higher doses. Based on the positive PK and safety results NeuroVive is moving rapidly to initiate the next study in Europe that will include repeated dosing (multiple ascending dose; MAD) in healthy volunteers and patients. Detailed analysis of the complete data set is ongoing. There is a huge unmet medical need for medicines that treat genetic mitochondrial diseases. Patients can have severe symptoms in any organ and have significantly reduced life-expectancy. These diseases are rare diseases for which there are almost no registered medicines. “We are very excited about the results from the first in human clinical trial of KL1333 and see them as clearly promising for the continued clinical development of this important program together with NeuroVive,” commented Yungjin Pharm CEO & President Chae J. Lee. NeuroVive will now, together with a leading global contract research organization (CRO), rapidly progress the planning and preparation of the phase I MAD study of KL1333 in healthy volunteers and genetic mitochondrial disease patients. The study is expected to commence in the second half of 2018. “With the convincing safety profile of KL1333 and favorable PK data, we will confidently bring this promising program forward in development with the highest priority. The next important step is the clinical phase I MAD study, which will take us further towards the goal of offering a novel treatment to patients with severe genetic mitochondrial disease with few or no treatment options,” said NeuroVive CEO Erik Kinnman. The MAD study will consist of two parts; a dose escalation in healthy volunteers, and also multiple dosing of patients with genetic mitochondrial disease. The purpose of the study is to further investigate safety and pharmacokinetics of KL1333 prior to initiating a phase II efficacy clinical trial. The study will be conducted at sites in the UK and results are expected in the first half of 2019. This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 11:00 a.m. CEST on 21 May 2018. For more information please contact: Daniel Schale, Director of Communications +46 (0)46-275 62 21, ir@neurovive.com NeuroVive Pharmaceutical AB (publ) Medicon Village, SE-223 81 Lund, Sweden Tel: +46 (0)46 275 62 20 (switchboard) info@neurovive.com, www.neurovive.com About the KL1333 SAD study The study is a dose block-randomized, double-blind, placebo-controlled, single-dose, dose-escalation, phase I clinical study. 25 ,50, 100, 400, 600, 800 mg of KL1333 was administered in 60 healthy volunteers to investigate pharmacokinetics, safety and tolerability. About KL1333 KL1333 is a potent modulator of the cellular levels of NAD+, a central coenzyme in the cell’s energy metabolism. KL1333 has in preclinical models been demonstrated to increase mitochondrial energy output, reduce lactate accumulation, diminish the formation of free radicals, and to have long-term beneficial effects on energy metabolism such as the formation of new mitochondria. It is in clinical development stage intended to document the use for chronic oral treatment in primary genetic mitochondrial disorders such as MELAS, KSS, PEO, Pearson and MERRF. KL1333 is currently being evaluated in clinical phase I-studies and has been granted orphan drug designation in both the United States and Europe. About genetic mitochondrial disease Genetic mitochondrial diseases are metabolic diseases that affect the ability of cells to convert energy. The disorders can manifest differently depending on the organs affected by the genetic defects and are viewed as syndromes. An estimated 12 in every 100,000 people suffer from a mitochondrial disease. Mitochondrial diseases often present in early childhood and lead to severe symptoms, such as stunted growth, heart failure and rhythm disturbances, dementia, movement disorders, stroke-like episodes, deafness, blindness, droopy eyelids, limited mobility of the eyes, vomiting and seizures. About NeuroVive  NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine, with one project in clinical phase II development for the prevention of moderate to severe traumatic brain injury (NeuroSTAT®) and one project in clinical phase I (KL1333) for genetic mitochondrial diseases. The R&D portfolio consists of several late stage research programs in areas ranging from genetic mitochondrial disorders to cancer and metabolic diseases such as NASH. The company’s strategy is to advance drugs for rare diseases through clinical development and into the market. The strategy for projects within larger indications outside the core focus area is out-licensing in the preclinical phase. NeuroVive is listed on Nasdaq Stockholm, Sweden (ticker: NVP). The share is also traded on the OTCQX Best Market in the US (OTC: NEVPF). About Yungjin Pharm Yungjin Pharm Co. Ltd., established in 1952, has been playing a major role as a forerunner in the Korean pharmaceutical industry for half a century. With the inspiring mission statement, "To relieve the suffering of mankind from diseases with our innovative, effective and safe pharmaceutical products", they have shown a successful contribution not only within Korea, but also through global expansion. As a result, they have received a total of 25 awards including the President Award for Superior Product Development, the Prime Minister Award, Industry Award and many more. These accomplishments demonstrate their sustainability and commitment to the development of innovative products and business excellence in both overseas and domestic segments. The company is listed on the South Korean stock market, KOSPI (KRX 003520).

Mr Green and Gamingzone establish a joint venture for esports

Mr Green and Gamingzone Entertainment have established a joint venture to create a new community for esports fans with focus on entertainment, news and gaming possibilities. Mr Green runs several iGaming sites, such as Mr Green and Redbet. Gamingzone Entertainment is specialised in esports and gaming entertainment. The new joint venture will have a new, not yet decided, brand. The joint venture is owned to 55 per cent by Mr Green and to 45 per cent by Gamingzone Entertainment. Karl Mikael Cakste, one of the founders of Gamingzone, has initially been appointed CEO. ”Esports is a quickly growing, global phenomena and an increasing number of fans is spending time on gaming as well as different kind of videos. Experts believe this can become as huge as traditional sports. We want to be part of this development and create a presence among all its fans. In Gamingzone, we have found a partner who understands esports, content and entertainment”, says Per Norman, CEO of Mr Green. Gamingzone Entertainment was founded in 2017 by individuals with long backgrounds from the media and entertainment industry and companies such as MTG, TV4, Zodiak and Endemol Shine. The company has created the reality show GAMERZ where future talents within the game Counterstrike Global Offensive get the opportunity to become esports professionals. ”Entertainment and betting within esports is still immature. We are convinced that there are interesting and entertaining ways of offering the fans something better than what we have seen so far”, says Karl Mikael Cakste. “We are happy to partner with Mr Green which is an established, knowledgeable iGaming company that acts responsibly and is long-term.” ”Our main ambition is to create a community where esports fans from the entire world love to spend time. People of the age of 18 and older who wants to bet will in due time be offered that opportunity under just and safe conditions”, concludes Cakste. The new esports community will launch during the fall 2018. For further information, please contact: Per Norman, CEO of Mr Green & Co AB, tel. +46 (0) 722 30 9191, per.norman@mrg.se Åse Lindskog, Communication and IR, tel. +46 (0) 730 24 48 72, ase.lindskog@mrg.se Karl Mikael Cakste, CEO of Gamingzone Entertainment, tel. +46 (0) 70 778 87 87, kmc@gze.global Mr Green is a leading online gaming company with operations in twelve countries. The business concept is to offer entertainment and a first-class gaming experience in a responsible environment. The business was founded in 2007 and has developed into a well-established online gaming company with a broad customer offer and a strong globally viable brand. In 2017, Mr Green generated sales of SEK 1,192.0 million and the company has over 300 employees. The headquarters and technical development are based in Stockholm, and operations in Malta. Mr Green has gaming licenses in Malta, UK, Italy, casino license in Denmark and Sportsbook license in Ireland. The company is listed on Nasdaq Stockholm’s Mid Cap segment. Read more at www.mrg.se. Gamingzone Entertainment is an entertainment company in esports focused on creating narrative and entertaining original e-sports content. The founders have a background from TV4, MTG and Endemol Shine and have been involved in productions of Big Brother, Idol, Survivor, Deal or no deal and more. Read more at www.gze.se

Information in the Swedish media regarding a supervisory matter within Handelsbanken’s UK branch

Swedish media are today reporting on a matter relating to the Swedish Financial Supervisory Authority’s supervision of Handelsbanken’s UK operations. Among other things, this matter relates to questions that the Bank previously discussed and reported in its Pillar 3 Report, which was published in February 2018.  It is important to emphasise that, in the Bank’s assessment, the observations made by the Supervisory Authority do not infer an increased risk of loan losses within Handelsbanken UK. This supervisory matter concerns, for example, how decision data for risk rating in the Bank’s IRB models and credit decisions is set out and documented.  In the UK, Handelsbanken applies the same strict credit process and risk tolerance level as in the Group as a whole. Over the decades, these methods, together with our decentralised business model, have resulted in Handelsbanken maintaining significantly lower loan losses than its peers. For a while now, there has been an ongoing dialogue between the Bank and the Swedish Financial Supervisory Authority. The purpose of this is to ensure that the Bank can make the improvements expected by the Authority in the best possible manner. In recent years, the Bank has taken measures to improve its procedures, processes and documentation of decision data, and its risk rating of credits.  The Bank’s actual loan losses are lower than the levels that have been estimated by the Bank’s Internal Risk-Based approaches (known as IRB models), which shows that Handelsbanken has satisfactory margins.  In addition, extensive annual validations of the Bank’s IRB models are carried out by the Bank’s unit for Independent Risk Control. One aim of this is to ensure that the models are used correctly and consistently throughout the Bank.  A letter from the Authority of the type referred to in the media is a standard part of a supervisory relationship. The aim is to enable the Bank to do fact-checking and submit its opinions. In other words, the letter does not constitute the final position of the authority.For further information, please contact:Mikael Sörensen, CEO Handelsbanken UK, + 46 8–22 92 20Katarina Grönwall, Chief Communications Officer +46 72–203 32 63Lars Höglund, Head of Investor Relations +46 8–701 51 70, +46 70–345 51 70Johan Wallqvist, Head of Group Media Relations, +46 8–701 80 47,+46 72–206 34 50For more information about Handelsbanken, see: www.handelsbanken.com  

Management team appointed for the Alma Consumer business unit

Alma Media Corporation                                   Press Release 21 May 2018 MANAGEMENT TEAM APPOINTED FOR THE ALMA CONSUMER BUSINESS UNIT Alma Media combined the Alma News & Life and Alma Regions business segments in April 2018 to create Alma Consumer, a business segment focused on consumer media. The business unit management team for the new segment has now been appointed. The members of the management team in charge of the Alma Consumer business unit’s operations are as follows: Kari Kivelä (Senior Vice President, Alma Consumer), Santtu Elsinen (technology), Katja Haikarainen (HR), Tiina Järvilehto (media sales), Matti Käki (printing and distribution, Alma Manu Oy), Tomi Lähdeniemi (editorial teams), Pauliina Makkonen (content sales), Inka Partanen (digital development and technology), Marika Schugk (marketing), Timo Välkkynen (finance) and Jonna Wikström (marketing, on maternity leave).   “The integration planning of Alma Consumer’s various functions is currently underway and progressing well. The key focus areas for the development of the business have been clarified. Printing, distribution, digital media, digital content sales and digital advertising are areas in which we have been able to respond to the challenges presented by the operating environment, achieve renewal and create growth. Leveraging technology will continue to play a very important role in the development of Alma Consumer’s content sales as well as in developing new and even more effective advertising solutions and then offering them to advertisers,” says Kari Kivelä, Senior Vice President, Alma Consumer.   More information:Kari Kivelä, Senior Vice President, Alma Consumer, tel. +358 (0)10 665 2032 

Autoliv provides update on planned Veoneer spin-off

Veoneer, Inc. has filed an amendment to its Registration Statement on Form 10 with the U.S. Securities and Exchange Commission (SEC) in connection with its planned spin-off from Autoliv. The amendment includes unaudited pro forma condensed combined financial statements which illustrate the financial impacts of the spin-off and related transactions, financial information of Veoneer for the first quarter of 2018 and information regarding certain expected directors of Veoneer following completion of the spin-off. The amendment to the Form 10 further specifies that related to the spin-off, Autoliv intends to provide total cash liquidity of approximately $1 billion (funded through a mixture of new external funding and existing cash). Autoliv’s Board had previously instructed management to assess Veoneer’s total cash liquidity needs of up to $1.2 billion. The unaudited pro forma condensed combined financial statements have been derived from the historical combined financial statements and the unaudited condensed combined interim financial statements of Veoneer with adjustments meant to give effect to the spin-off and related transactions. The unaudited pro forma condensed combined financial statements are for informational purposes only and do not purport to represent what Veoneer’s financial position and results of operations actually would have been had the spin-off and related transactions occurred on the dates indicated, or to project Veoneer’s financial performance for any future period. A copy of the registration statement is available for review at www.sec.gov under the name Veoneer, Inc. https://www.sec.gov/Archives/edgar/data/1733186/000119312518168532/0001193125-18-168532-index.htm Trading in Veoneer common stock and Swedish Depository Receipts is anticipated to begin in the early part of the third quarter of 2018 with listings on the New York Stock Exchange and Nasdaq Stockholm, respectively. Inquiries:  Media: Thomas Jönsson, Corporate Communications,   Tel +46 (0)8 5872 0627 Investors & Analysts: Anders Trapp, Investor Relations, Tel +46 (0)8 58 72 06 71 Investors & Analysts: Ray Pekar, Investor Relations, Tel, +1 (248) 794 4537 About Autoliv Autoliv, Inc. is the worldwide leader in automotive safety systems, and through its subsidiaries develops and manufactures automotive safety systems for all major automotive manufacturers in the world. Together with its joint ventures, Autoliv has more than 72,000 employees in 27 countries. In addition, the Company has 23 technical centers in nine countries around the world, with 19 test tracks, more than any other automotive safety supplier. Sales in 2017 amounted to about US $10.4 billion. The Company’s shares are listed on the New York Stock Exchange (NYSE: ALV) and its Swedish Depository Receipts on Nasdaq Stockholm (ALIV sdb). For more information about Autoliv, please visit our company website at www.autoliv.com. Safe Harbor Statement This release contains statements that are not historical facts but rather forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those that address activities, events or developments that Autoliv, Inc. or its management believes or anticipates may occur in the future, including those related to the intended spin-off of Autoliv’s Electronics business, the timing of such spin-off, whether the spin-off is ultimately consummated, the timing and amount of the capital injection into Veoneer and the expected performance of Autoliv and Veoneer following completion of the spin-off. All forward-looking statements are based upon our current expectations, various assumptions and/or data available from third parties. Our expectations and assumptions are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties and other factors which may cause actual future results, performance or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements. Numerous risks, uncertainties and other factors may cause actual results to differ materially from those set out in the forward-looking statements, including general economic conditions and fluctuations in the global automotive market. For any forward-looking statements contained in this or any other document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we assume no obligation to update publicly or revise any forward-looking statements in light of new information or future events, except as required by law.

Camanio Care writes agreement with Vital Integration

Camanio Care AB increases the involvement with Vital Integration by an exclusive license agreement, and an intensified collaboration by the employment of key figures. By this license agreement, Camanio Care has the exclusive right to sell, use, develop and integrate Vital’s solutions with Camanio’s existing products during at least four years. Camanio Care thereby strengthens their offer and competence within IoT, and continues their transition from a research phase towards a commercial phase, where digital infrastructure within welfare is a key factor. Together, Vital Integration and Camanio Care become welfare operators who can offer a coherent infrastructure for health care within the home. The agreement also results in a business model based on SaaS (software as a service), which increases the predictability of future income. Strengthens the business area Digital Care The business area Digital Care has so far been based on the product Giraff, Camanio Care’s telepresence robot. With the new agreement, Camanio’s and Vital’s solutions become a strong and unique combination for actors within health care. There is an increasing need for qualitative digital solutions for health care services in people’s homes, where both services and products can be delivered as an overall solution. This new collective offer strengthens Camanio’s vision of delivering safety, independence and life quality for the elderly and people with disabilities. -This is strategically an important step forward for us. We are entering this agreement exactly at the right time in order to really being able to meet our customers’ needs for digital care. We are certain that this is an area which will continue to have a strong growth for the coming years. Vital Integration has a unique competence within architecture of systems, design as well as the integration of welfare services. We will protect Vital Integrations’ existing clients and suppliers by having a close dialogue with all the partners involved. With Camanio’s resources, we will be able to strengthen both the collaboration and our offer, says Catharina Borgenstierna, CEO Camanio Care. -We are very happy and proud to be able to work through, and together with, Camanio Care. From now we start building the possibilities of delivering a strong overall solution with both platforms and products. Our collaboration has so far been successful and we share both visions and values. With a collective organization, we do not only strengthen our offer but also our ability to deliver. Camanio is a strong actor within this area, our network completes one another’s, and we have already identified several important business opportunities that none of us have been able to make use of on our own, says Magnus Cederström, part-owner Vital Integration. Advantages of Vital’s welfare broadband -        Technology-neutral by an open platform for welfare technology. -        Network-neutral by the possibility of using several networks. -        Safe interface by several available connections. -        User- and administration of authorities that guarantees the chain of responsibility between different partners within welfare services at home. -        Infrastructure which enables action-driven supervision. The Swedish market for digital care -        Today, approximately 203 000 people in Sweden has safety alarms[1]  -        There is a large technical shift that takes place in Sweden’s municipalities, where all the analogue safety alarms are being replaced for digital ones, and the whole area of alarms transcends to digital technology[2] . -        Approximately 30 municipalities carry out procurements equivalent to ca 300 million SEK annually. -        The government has earmarked an additional government grant of 350 million SEK in the spring-budget for 2018 for new technology within elderly care. -        More and more municipalities are adopting the model of purchasing several services at the same time, which can be delivered by a joint welfare environment. Camanio Care is one of the few well established actors within Swedish welfare technology, who has had a close dialogue and collaboration with municipalities and health care sector in Sweden since 2012. About Vital Integration VITAL Integration is an IoT-company within welfare technology, with focus on infrastructure for transfer of data within the healthcare sector. As an operator for welfare, the company offers integrated solutions for a smart home that strengthens the individual’s independence and safety, both inside and outside the home. This is achieved though VITAL SmartCare, a service platform that collects and transfers data from all sensors installed in the home such as mobile personal alarms, cameras, door locks, stove protections, GPS etc. to care professionals and relatives. VITAL SmartCare is the central hub in the net for Digital care, with an attractive business model that builds on re-occurring income based on monthly fees per service and per user. For further information, please contact:Catharina Borgenstierna, CEOTelephone: 0733-93 00 07E-mail: catharina.borgenstierna@camanio.com About Camanio CareCamanio Care is a care tech company, developing services with the individual in focus. The company offers solutions within robotics, assistive devices, and gamification, with products such as BikeAround™, Bestic®, and Giraff™. Through three focus areas; Active Life, Mealtime and Digital Care, the company wishes to support people’s basic needs and increase the competence and quality within health care. Camanio Care has its headquarters in Stockholm, Sweden, a subsidiary in the U.S., as well as distributors in China, Australia and ten European countries. Subscribe to our newsletter and/or read more about us, Camanio Care at: www.camanio.com.    Find us on the following channels:                              This information is information that Camanio Care is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, on May 21th, 2018.  ---------------------------------------------------------------------- [1]  https://www.socialstyrelsen.se/publikationer2015/2015-9-8 [2]  http://www.mfd.se/kunskapsomraden/digital-teknik/om-digital-teknik/exempel-pa-digital-teknik/digitala-trygghetslarm/

Talkpool launches Nordic IoT Networks

This initiative is targeted to meet the increasing customer demand for IoT connectivity fueled by the growing number of IoT projects and sensors deployed.  “LoRa is a low power wide area network radio technology, optimized for very long range and millions of connected devices at low cost. This enables solutions that previously were not economically viable or even possible” says Stefan Lindgren, CTO of Talkpool.  Phase one of the network roll out is already in progress and will provide coverage in the regions of Stockholm, Gothenburg, Malmoe/Lund and Uppsala. Subsequent phases will provide coverage across Sweden, Norway and Denmark.   “The Nordic countries continue to be at the global forefront of the IoT. The average number of connected things per person in the region is expected to be four times as many as in the rest of the world by 2021. We believe that coverage provided by Nordic IoT Networks combined with the collaborative business model will further boost the Nordic IoT market” adds Mats Björs Chairman of the Niot Board.  Niot will build and operate a LoRa network but also cooperate with other network operators to consolidate and extend the network coverage. All network access will however be provided by partners. Talkpool will be the first solution provider and more partner companies are soon to follow.  “We have a lot of interesting projects in our pipeline - soon to be announced and they all need LoRa connectivity concludes” Stefan Lindgren, CTO of Talkpool.  Talkpool will also be a minority owner of Nordic IoT Networks and provide LoRa network expertise and manage the roll out while the investor group will finance the company.  For more information: Henrik LindgrenCEO Nordic IoT Networkshenrik.lindgren@niotnet.com About TalkpoolTalkpool provides IoT solutions and telecommunication network services globally. Through its cutting-edge technical expertise, long experience and agile business model, Talkpool offers global telecom vendors and operators high-quality services on short notice no matter the location. Moreover, Talkpool is one of few companies with actual solutions and contracts in place in the exciting IoT-market. Remium Nordic Holding AB is Talkpool’s Certified Advisor. www.talkpool.com This information is inside information that Talkpool AG (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 17.00 CET on May 21, 2018.

Kappahl becomes a member of the Sustainable Apparel Coalition

Swedish fashion chain KappAhl has decided to become a member of the Sustainable Apparel Coalition to help speed up the pace of change in sustainable working methods and solutions in the fashion industry. As part of the SAC, we can work with other players in the industry - purchasers, suppliers, researchers, investors and consumers - to coordinate efforts to achieve greater transparency and better results in moving the fashion industry towards a more sustainable future.  KappAhl is now in the process of developing their working methods using the SAC’s Higg Index suite of tools. The goal is to set clear standards for the entire industry to measure and assess the sustainability performance of suppliers and products.      “A harmonised approach within the industry will have a positive impact on our entire value chain and bring greater transparency to the industry. This is the route to achieving a sustainable fashion industry,” says Fredrika Klarén, Head of Sustainability at KappAhl.   Sustainable Apparel Coalition (SAC) is an organisation working to create a sustainable fashion industry with the vision of an industry that causes no harm to the environment and has a positive impact on people and society. SAC’s Higg Index is a suite of tools designed to measure and assess the sustainability performance of suppliers and products and promote long-term sustainable improvements for factory workers, local communities and the environment. Through harmonised working methods and processes, the industry will also provide the transparency that is increasingly being demanded by consumers. More info: www.apparelcoalition.org 

NSW Health, Australia’s largest public health system, has selected Sectra as preferred vendor for a large enterprise imaging IT solution

NSW Health has clearly articulated the need for a PACS/RIS and a shared platform with the ability to collaborate around medical images and information across its multiple Local Health Districts in NSW. The hospitals taking part manage a joint volume of around 3 million imaging exams per year. Procurement of a consolidated medical image (PACS) and information (RIS) solution will support NSW Health’s aim to deliver world-class integrated clinical care.  “We are happy to confirm that Sectra has been selected as the preferred vendor for the PACS/RIS solution for 10 Local Health Districts and NSW Pathology. The solution was selected by clinicians, radiology subject matter experts and ICT professionals which ensures that the best available solution will be delivered to support our highly skilled clinical staff in providing excellent patient care. We expect that the solution will also provide significantly improved capability for result notification, scheduling, and secure sharing of images across the health system,” says Dr Zoran Bolevich, Chief Executive of eHealth NSW and Chief Information Officer for NSW Health. Subject to successful completion of the Proof of Concept phase, NSW Health plans to sign a 10-year contract with Sectra for the implementation and ongoing support of a PACS/RIS solution for 10 Local Health Districts and NSW Pathology. The potential contract includes substantial deliveries from sub-contractors. The final agreement is subject to a successful finalization of contract terms and conditions. About Sectra Enterprise Image Management Sectra’s enterprise imaging portfolio provides a unified strategy for all imaging needs and improves patient outcome while lowering operational costs. The scalable and modular solution supports the most image-intense departments—radiology, pathology, cardiology and orthopaedics. Being built on the same technical platform, customers can easily extend a departmental solution to create a comprehensive VNA. Capture, store, access, share, and collaborate around medical multimedia throughout the entire enterprise and beyond. Read more about Sectra’s solutions and why Sectra PACS is “Best in KLAS” for a fifth consecutive year at www.sectra.com/medical/. 

Stora Enso accelerates growth in renewable materials by co-operating with the startup Sulapac

Through the joint development agreement, Stora Enso will licence Sulapac’s materials and technology, and begin the development of fully renewable caps and closures for liquid packages. Other areas for joint development work include food packages and packages for consumer electronics.  “At Stora Enso we believe that everything that’s made with fossil-based materials today can be made from a tree tomorrow. Our future growth comes from innovations in renewable materials,” says Annica Bresky, EVP Consumer Board at Stora Enso. “With our partners, such as Sulapac, we drive these innovations to create the packaging of the future.” “The World needs material solutions that are one hundred percent biodegradable. Sulapac material has all the benefits of plastic yet it completely biodegrades without the issues of microplastic. With Stora Enso’s global expertise we can really speed up the global launch of our Sulapac material,” says Suvi Haimi, Sulapac CEO. The cooperation between the companies began in 2017 through Stora Enso’s Accelerator programme, which involves partnering with Aalto University and start-ups to ideate and innovate around renewable products. Stora Enso is the first customer to use Sulapac’s material and technology license. About SulapacSulapac is a fully biodegradable and microplastic free material made of renewable and sustainable raw materials. Sulapac products are designed for brands that want to eliminate plastic waste and demonstrate a genuine commitment to sustainability through the use of premium ecological material. The company was founded in 2016 by Suvi Haimi and Laura Kyllönen and is based in Helsinki, Finland. sulapac.com   For further information, please contact:Ulrika Lilja, EVP, Communications, tel. +46 72 221 9228 Part of the bioeconomy, Stora Enso is a leading provider of renewable solutions in packaging, biomaterials, wooden constructions and paper globally. We believe that everything that is made from fossil-based materials today can be made from a tree tomorrow. Stora Enso has some 26 000 employees in over 30 countries. Our sales in 2017 were EUR 10 billion. Stora Enso shares are listed on Nasdaq Helsinki (STEAV, STERV) and Nasdaq Stockholm (STE A, STE R). In addition, the shares are traded in the USA as ADRs (SEOAY). storaenso.com   STORA ENSO OYJ 

AktieTorget changes name to Spotlight Stock Market

We have had a clear purpose since the start of AktieTorget 20 years ago - we want to help companies to grow. The foundation is, just like then, to offer a well-functioning marketplace where growth companies can raise capital to be able to grow in the pace they would like to. Investors are at the same time getting the opportunity to be shareholders in interesting companies.  We know that it is not enough to “only” offer trading in a company’s share, there are more needs and wishes to fulfill. Our goal is to help growth companies to reach their full potential.  The actors in our business has looked and talked the same way for a long time. With the name Spotlight we want to change that, we want to change the way people think about stock trading and listed companies. It is essentially a positive experience – companies get the opportunity to grow and investors have the possibility to follow the company on their journey. For us, this is a strategic shift from traditional market place for trading in shares to becoming a stronger platform with focus on placing our growth companies in the spotlight. Our new identity is much more modern, fresh and clear and we are convinced that it will contribute to the understanding of our purpose with Spotlight Stock Market. Since the start we have developed our services to be simpler, safer and more visible for companies to be listed with us. During the last year we have launched “in focus”, an extra safety for our newly listed companies. We are also offering extra media coverage and analysis for all our companies. We are soon launching our solution for the Danish market, and this fall we are presenting two new segments - one for companies on their way to listing and one for our larger companies. Our goal is to continue taking big steps forward. För mer information, vänligen kontakta: Peter GöncziCEO, Spotlight Stock Market+46 8 511 68 00peter.gonczi@spotlightstockmarket.se Christina PloomCOO and Head of Market Surveillance+46 8 511 68 00christina.ploom@spotlightstockmarket.se

Invuo considers legal actions related to the AJ Group transaction

Following today’s announcement of Invuo Technologies AB´s (“Invuo”) sale of assets related to Seamless Distribution Systems AB (“SDS”), Invuo confirms that it will now consider to take legal actions as a result of the non-executed transaction with AJ Group Holdings Ltd (“AJ Group”). As announced in a press release on March 6, 2018, AJ Group has signed a subscription undertaking which represented a total investment, in Invuo shares and SDS related assets, of SEK 52 million. As AJ Group has failed to fulfil its legal obligations under the subscription undertaking, Invuo will consider taking legal actions as a result of this severe breach of contract. In addition, and as announced separately, Sheliza Jamal, has resigned from the Invuo Board.   For further information, please contact:John Longhurst, CEO, john.longhurst@invuo.com, +46 8 564 878 00   This information is such that Invuo Technologies AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. This information was submitted for publication, through the agency of the contact person set out above, at 08.30 CEST on May 22, 2018.   About InvuoSince 2001 Invuo has been providing its proprietary solutions and systems for mobile phone transactions. Invuo operates in two main business areas; mobile phone payment solutions provided through the brand MeaWallet™, and distribution of e-products. www.invuo.com

NeuroVive Pharmaceutical AB Interim report January – March 2018

Business operations Important events January – March 2018 · NeuroVive decided to conduct a rights issue for the continued development of the company’s drug projects following shareholder approval at an Extraordinary General Meeting. · The company reported positive efficacy data in an experimental model, entailing a breakthrough for the NVP025 mitochondrial myopathy project. · NeuroVive presented the company at the Stockholm Corporate Finance Life Science Seminar. · The company presented its NASH research at the 2nd Annual H.C. Wainwright NASH Investor Conference. Important events after the end of the period · NeuroVive conducted an oversubscribed rights issue. · The company announced that the last patient had been recruited to the first KL1333 Phase I clinical study. · KL1333 was granted orphan drug designation by the FDA in the US. · NeuroVive announced a collaboration with TRACK-TBI, a network of world-class traumatic brain injury (TBI) researchers. · NeuroVive held Annual General Meeting on 27 April in Lund, Sweden. · NeuroVive and Yungjin reported positive KL1333 phase I clinical study results, paving the way for further clinical development. Financial information  First quarter (January – March 2018)  · Net revenues were SEK 0 (27,000) and other operating income was SEK 174,000 (63,000) · Loss before tax was KSEK -13 053 (-21 390) · Loss per share* was SEK -0,25 (-0,40) · Diluted loss per share** was SEK -0,25 (-0,40) * Profit/loss for the period divided by average number of shares before dilution at the end of the period. ** Profit/loss for the period divided by average number of shares after dilution at the end of the period Please find the complete interim report attached below. This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 08:30 a.m. CEST on 22 May 2018. For more information please contact: Daniel Schale, Director of Communications +46 (0)46-275 62 21, ir@neurovive.com NeuroVive Pharmaceutical AB (publ) Medicon Village, SE-223 81 Lund, Sweden Tel: +46 (0)46 275 62 20 (switchboard) info@neurovive.com, www.neurovive.com About NeuroVive  NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine, with one project in clinical phase II development for the prevention of moderate to severe traumatic brain injury (NeuroSTAT®) and one project in clinical phase I (KL1333) for genetic mitochondrial diseases. The R&D portfolio consists of several late stage research programs in areas ranging from genetic mitochondrial disorders to cancer and metabolic diseases such as NASH. The company’s strategy is to advance drugs for rare diseases through clinical development and into the market. The strategy for projects within larger indications outside the core focus area is out-licensing in the preclinical phase. NeuroVive is listed on Nasdaq Stockholm, Sweden (ticker: NVP). The share is also traded on the OTCQX Best Market in the US (OTC: NEVPF).

Therese Hillman appointed new Group CEO of NetEnt

Therese Hillman has been Chief Financial Officer of NetEnt since January 2017 and acting CEO since March 2018. Before joining NetEnt, she worked in the e-commerce industry for 10 years and was the CEO of Gymgrossisten, a subsidiary of Qliro Group. She has also been a member of the Board of Unibet. Therese Hillman has an M.Sc. in Accounting and Finance from the Stockholm School of Economics. - ”We are pleased to appoint Therese Hillman as new Group CEO. Therese has a clear business focus and is an appreciated leader with great energy. NetEnt is pioneering the online gaming industry and is taking the next step to be at the forefront of business focus and innovation. With Therese's abilities, we get the right person to lead the company in the next growth phase", says NetEnt's Chairman of the Board, Fredrik Erbing. - ”It is with great enthusiasm, but also humility, that I am taking on the role as Group CEO of NetEnt. I look forward to drive the development of the industry together with our customers and employees and to deliver the best player experiences. This is how we can continue to create value for our customers, shareholders, players and employees”, says Therese Hillman. For additional information please contact:Fredrik Erbing, Chairman of the Board of Directors, NetEntPhone: +46 8 5785 4500 Roland Glasfors, Investor Relations & Corporate Strategy, NetEntPhone +46 760 024 863roland.glasfors@netent.com This information is information that NetEnt AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET on May 22nd, 2018. About NetEntNetEnt AB (publ) is a leading digital entertainment company, providing premium gaming solutions to the world’s most successful online casino operators. Since its inception in 1996, NetEnt has been a true pioneer in driving the market with thrilling games powered by a cutting-edge platform. NetEnt is committed to helping customers stay ahead of the competition, is listed on NASDAQ Stockholm (NET–B) and employs 1,000 people in Malta, Stockholm, Kiev, Krakow, Gothenburg, Gibraltar and New Jersey. www.netent.com

Update on Invuo’s financial position

In a press release dated May 17, 2018, Invuo Technologies AB (“Invuo”) announced that uncertainties related to the previously announced transaction with AJ Group Holding AB (“AJ Group”) had resulted in a situation where Invuo’s liquidity had become critical. In the press release the Company also announced it would seek alternatives to funding through AJ Group. As separately announced today, Invuo has agreed to sell assets related to Seamless Distribution Systems AB (“SDS”), for a total consideration of SEK 17.5 million. This injection of liquidity will allow Invuo to continue operations, and to invest in its two businesses, MeaWallet and eProducts. With the agreement to sell the SDS assets, uncertainty related to Invuo’s short-term liquidity position have been resolved. Based on the Company’s current business plan, which includes an acceleration of signed orders this year by MeaWallet, as well as that eProducts delivers break-even profit performance this year, the Company expects to maintain sufficient liquidity to be able to self-fund its activities at least until year-end 2018. An announcement related to the AJ Group transaction has been separately made today.   For further information, please contact:John Longhurst, CEO, john.longhurst@invuo.com, +46 8 564 878 00   This information is such that Invuo Technologies AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. This information was submitted for publication, through the agency of the contact person set out above, at 08.30 CEST on May 22, 2018.   About InvuoSince 2001 Invuo has been providing its proprietary solutions and systems for mobile phone transactions. Invuo operates in two main business areas; mobile phone payment solutions provided through the brand MeaWallet™, and distribution of e-products. www.invuo.com 

NetEnt holds a capital markets day – presenting more financial information and a new product initiative

The future profitable growth of NetEnt is expected to come from existing and new customers, new products, services and distribution channels, as well as new geographic markets in Europe, North America and Asia. CEO Therese Hillman comments: ”We have initiated changes to enable better execution of our strategy, focusing on cost control and new growth initiatives utilizing existing resources. Through a new, exciting product initiative we are now beta-launching a selection of our games on Facebook in the gaming form called Social Casino, which could generate new revenues in the mid- to longer-term perspective.” Regulated markets form an important part of NetEnt’s growth strategy and the Company aims to be ready to operate on the re-regulated Swedish market from the expected start on January 1, 2019, given that the new regulation takes places according to the most recent proposal. NetEnt’s current total revenues will be negatively impacted by an estimated 2.5 percentage points due to the proposed new gaming tax in Sweden. To increase knowledge about NetEnt’s business, the Company for the first time presents revenue split by geography. Based on player countries, NetEnt’s revenues were split according to the following table below. +--------------+-------+-------+-------+|Geography |Q1 2018|Q1 2017|FY 2017|+--------------+-------+-------+-------+|Sweden |14% |14% |14% |+--------------+-------+-------+-------+|Other Nordic |18% |21% |20% |+--------------+-------+-------+-------+|United Kingdom|14% |14% |14% |+--------------+-------+-------+-------+|Other Europe |47% |42% |43% |+--------------+-------+-------+-------+|Other World |8% |9% |9% |+--------------+-------+-------+-------+ Based on customer size classes, NetEnt’s revenues were split according to the following table below. +---------------+-----------------------+|Size class |Share of revenues, 2017|+---------------+-----------------------+|Customer 1-3 |21% |+---------------+-----------------------+|Customer 4-10 |27% |+---------------+-----------------------+|Customer 11-20 |17% |+---------------+-----------------------+|Customer 21-40 |17% |+---------------+-----------------------+|Other customers|17% |+---------------+-----------------------+ NetEnt reiterates its financial targets. NetEnt’s overall target is to further strengthen its market position, drive developments and grow faster than the market.Also, NetEnt is targeting shareholder cash returns of at least 60 percent of profit after tax, subject to the company’s long-term capital requirement.For additional information please contact:Therese Hillman, CEO of NetEntPhone: +46 8 5785 4500therese.hillman@netent.com Roland Glasfors, Investor Relations & Corporate Strategy, NetEntPhone +46 760 024 863roland.glasfors@netent.com This information is information that NetEnt AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:45 CET on May 22nd, 2018. About NetEntNetEnt AB (publ) is a leading digital entertainment company, providing premium gaming solutions to the world’s most successful online casino operators. Since its inception in 1996, NetEnt has been a true pioneer in driving the market with thrilling games powered by a cutting-edge platform. NetEnt is committed to helping customers stay ahead of the competition, is listed on NASDAQ Stockholm (NET–B) and employs 1,000 people in Malta, Stockholm, Kiev, Krakow, Gothenburg, Gibraltar and New Jersey. www.netent.com

Dignitana publishes Interim Financial Report for Q1 2018

The complete Q1 2018 Interim financial report is attached to this press release and may also be downloaded from the company website at http://www.dignitana.se/rapporter/ Interim Report – Summary ­­ Key RatiosDignitana Group Q1 2018 Q1 2017 Full Year 2017 Net revenues, TSEK                     6,127            22,941   5,897Total revenues TSEK                     6,177            23,133   5,988Net profit after                   (8,109)            (42,355)financial items, TSEK (8,950)Cash and bank balances,                   17,995              1,018TSEK 22,185Earnings per share -0.2 -0.4 -2.1before and afterdilution, SEK Dignitana AB Q1 2018 Q1 2017 Full Year 2017 Net revenues, TSEK                     5,312            18,300   4,444Total revenues TSEK                     5,362            18,490   4,535Net profit after                   (8,189)            (42,277)financial items, TSEK (9,027)Cash and bank balances,                   17,762                606TSEK 19,636 Significant events during the period ·  The DigniTherm™ Click Cap was introduced to facilities in December 2017 and the roll-out to all U.S. facilities was completed in Q1 2018. ·  13 machines were installed at 12 sites in the US in Q1. ·  Transition of operations from Lund, Sweden to the U.S. was announced and initiated in Q4 2017 and continued in Q1. It was successfully completed in April, two months ahead of schedule. Dignitana AB remains in Lund. ·  The Rights offering which was begun in Q4 2017 was fully subscribed and funding was completed in early January 2018. ·  At an Extraordinary General Meeting 16 March 2018 Thomas Kelly, Ingrid Atteryd Heiman, and Mikael Wahlgren were appointed to the Board of Directors with Thomas Kelly designated as Chairman of the Board for Dignitana AB. ·  In March James McKinney was named President and COO of Dignitana, Inc. ·  In March Dignitana initiated an application with the American Medical Association for a unique CPT Code for scalp cooling to provide a pathway for universal scalp cooling coverage. The decision will be announced by the AMA in June. Significant events after the first quarter · Thomas Kelly, Bill Cronin, Ingrid Atteryd Heiman, and Mikael Wahlgren were re-elected to the Board of Directors at the Annual General Meeting 24 April 2018 with Thomas Kelly as Chairman. ·  In April Dignitana announced the transfer of management of all European installations of DigniCap from Sysmex to Dignitana. ·  Contracts for 4 locations have been signed since 1 April 2018 representing 4 machines. ·  Agreed to expand unit locations with Florida Cancer Specialists. ·  Contracted with Atlantic Health System to provide scalp cooling services. ·  Dignitana initiated its first direct-to-customer lease unit lease transaction for two locations in Spain. To download the full report, go to http://www.dignitana.se/rapporter/ This information is information that Dignitana AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, by the above contact, for publication at 09:00 (CET), 22 May 2018. 

European patent approval for Episurf Medical’s individualised surgical instruments

The European patent office EPO has announced its intention to grant another European patent for Episurf Medical (NASDAQ: EPIS B). The patent being approved is within the area of individualised surgical instruments with a focus on the drill guide for the Episealer® Femoral Twin implant. This is the first patent approval within this patent family. “This patent covers the drill guide for the Episealer® Femoral Twin implant, which is the implant that shows the highest sales volumes. Extensive IP protection within this field is therefore important for us”, comments Pål Ryfors, CEO, Episurf Medical.   For more  information, please contact: Pål Ryfors, CEO, Episurf Medical Tel:+46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalised treatment alternatives. Episurf Medical’s Episealer® personalised implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com. This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 10.00 CEST on 22 May 2018.

AcadeMedia publishes the Nomination Committee for the AGM in 2018

The nomination committee shall comprise one representative for each of the three largest shareholders based on ownership of the company as per the end of the financial year’s third quarter. The chairman of the board shall be a co-opted member (Sw. adjungerad). The Nomination Committee, which is appointed in accordance with the principles adopted by the Annual General Meeting November 24, 2017 consists of: Rune Andersson, Mellby GårdErik Durhan, Nordea FundsUlrika Danielson, Andra AP-fonden For more informationhttps://corporate.academedia.se/bolagsstyrning/valberedning/ Shareholders who wish to submit proposals to the Nomination Committee for the Annual General Meeting on November 22, 2018 can do so by e-mail to valberedning@academedia.se. Proposals should be submitted to the Nomination Committee before October 1, 2018. For more information, please contact: Eola Änggård Runsten, CFOTelephone: +46 8 794 4240E-mail: eola.runsten@academedia.se About AcadeMediaAcadeMedia creates opportunities for people to develop. The 15,800 employees at our 650 preschools, compulsory schools, upper secondary schools and adult education centres share a common focus on quality and development. Our 176,000 children and students are provided with a high quality education, giving them the best conditions to attain both learning objectives and their full potential as individuals. AcadeMedia is Northern Europe ́s largest education company, with locations/facilities/presence in Sweden, Norway and Germany. Our size gives us the capacity to be a robust, long term partner to the communities we serve. More information about AcadeMedia is available on www.academedia.se.

Qliro Group - Annual General Meeting 2018

The AGM adopted the income statement, the balance sheet, the consolidated income statement and the consolidated balance sheet for the year 2017. The AGM approved that the retained earnings, the share premium reserve and the result for the year, corresponding to a total of SEK 668,441,441 be carried forward. The AGM discharged the Board and the CEO from liability for 2017. The AGM re-elected Christoffer Häggblom, Daniel Mytnik, Jessica Pedroni Thorell and Erika Söderberg Johnson as directors of the Board and elected Andreas Bernström and Lennart Jacobsen as new directors of the Board. Furthermore, the AGM elected Christoffer Häggblom as Chairman of the Board. The AGM approved to re-elect the auditing firm KPMG AB as the company’s auditor for the period until the end of 2019 Annual General Meeting. The authorised public accountant Mårten Asplund will continue as the auditor-in-charge. The AGM approved remuneration for the Board and the auditor and procedure for the Nomination Committee (that shall apply until a resolution regarding a change of the procedure for the Nomination Committee is resolved by the general meeting). The AGM approved the guidelines for remuneration for senior executives as well as the principles and scope for a performance share plan with a similar structure as the long-term  incentive plans adopted in 2011-2017, a synthetic call option plan (with a similar structure as the synthetic call option plans adopted in 2016 and 2017) based on the underlying value growth in Qliro Group's subsidiary Qliro Financial Services (Qliro AB), and to transfer own shares to the participants in accordance with the conditions of the plans. The AGM also resolved on hedging arrangements for the programmes, comprising authorisations for the Board to resolve on a new issue of no more than 1,807,000 class C shares and re-purchase of all class C shares in the company. The AGM authorised the Board to pass a resolution on one or more occasions for the period up until the next Annual General Meeting to repurchase so many of the company’s own ordinary shares that Qliro Group's holdings do not at any time exceed 10 per cent of the total number of issued shares in Qliro Group. The AGM resolved to dismiss the shareholder’s proposal. At a statutory meeting of the Board of Directors following the AGM, the Audit and Remuneration Committees were appointed. Erika Söderberg Johnson was appointed Chairman of the Audit Committee, while Daniel Mytnik and Jessica Pedroni Thorell were appointed as Audit Committee members. Daniel Mytnik was appointed Chairman of the Remuneration Committee, while Christoffer Häggblom and Jessica Pedroni Thorell were appointed as Remuneration Committee members. For further information, please visit www.qlirogroup.com, or contact: Marcus Lindqvist, CEOTelephone: +46 10 703 20 00 Niclas Lilja, Head of IRTelephone: +46 736 511 363E-mail: ir@qlirogroup.com About Qliro GroupQliro Group is a leading Nordic e-commerce group in consumer goods, lifestyle products and related financial services. Qliro Group operates the leading Nordic marketplace CDON.COM, the online fashion brand Nelly.com and Qliro Financial Services that offers financial services to merchants and consumers. In 2017 the Group had sales of SEK 3.4 billion. Qliro Group’s shares are listed on the Nasdaq Stockholm Mid-Cap segment under the ticker symbol QLRO.

Eagle Filters awarded Excellent Gas Turbine Filtration Technology Innovation of the Year Award at the 5th China Gas Turbine Focus Conference

The Gas Turbine Focus Awards Ceremony celebrates the leading enterprises in China and beyond. It’s also an appeal to encourage the new rising and promising companies.  China is a potentially significant market for Eagle Filters’ technology. The total electricity produced by Combined Cycle Gas Turbine (CCGT) plants in China is estimated to be 188 TWh, which presents a significant opportunity for Eagle Filters in the Chinese market. Eagle Filters has already proven that it can provide significant fuel savings and efficiency gains for gas power plants in other markets such as the US and Europe. Their filtration solutions are compatible with the majority of filter housings already in place at CCGT’s, so they can be deployed without the need for changes on the part of gas turbine managers. To provide an example of Eagle Filters’ potential in China, their technology could provide 3.2 million MWh of extra production (equivalent of two large power plants); 8 million GJ fuel savings (or 200 million m3of natural gas); and 450 000 tons of CO2 prevented if it were rolled out in all CCGT. Loudspring CEO Lassi Noponen: “Eagle Filters is a great example of a Loudspring company saving natural resources, in Eagle’s case natural gas. Eagle Filters supplies industry leading products to the energy industry and helps them save enormous amounts of fuel and thus reduce CO2 emissions. Saving a valuable resource like natural gas and optimizing its use is good for business and the planet”. Eagle Filters Vice-President Frank Vranken: “The 5th China Gas Turbine Focus Conference was a great opportunity to present our clean technology to a forum of scientific institutions, researchers and users of gas turbines. Being awarded as an innovative technology at this event only confirms our role as a leader and pioneer in China. Such acknowledgement motives us to do better day after day at Eagle Filters.” For more information about Eagle Filters and their technology please contact Frank Vranken at: frank.vranken@eaglefilters.fi

Cherry’s CEO under investigation by Swedish Economic Crime Authority

During the morning, the Swedish Economic Crime Authority has performed a search at the head office of Cherry AB and in relation to this event, the company’s CEO, Anders Holmgren, was arrested. Cherry will fully cooperate with the Economic Crime Authority in the investigation. During the period of the investigation, Gunnar Lind, chairman of the Cherry Audit Committee, will be acting CEO of Cherry. Cherry will return with more information as soon as more details can be presented.For further information, please contact:Morten Klein, Chairman of Cherry AB, +47 913 22 222, morten@kleingroup.noAnders Antonsson, IR & Communications: +46 709 994 970, anders.antonsson@cherry.se This information is information that Cherry AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above on 22 May 2018, at 2:30 p.m. CET. CHERRY IN BRIEF Cherry is a Swedish innovating and fast-growing company with operations in gaming, entertainment and media. The company was established in 1963 and today operates through five diversified business areas: Online Gaming, Game Development, Online Marketing, Gaming Technology, and Restaurant Casino. The objective is to grow organically in combination with strategic acquisitions of fast-growing companies. Cherry employs some 1,400 people and has about 6,700 shareholders. The company’s class B share is listed on the Nasdaq Stockholm exchange, Mid Cap segment. More information is available at www.cherry.se.

Active dialogues on six continents

Enviro's projects and dialogues around the world. The need for advanced technology combined with tried-and-true, verified commercial in-service experience is increasing in step with a multitude of trends. But that need is also thrown into sharp relief because alternative technologies and simpler solutions are quite simply not meeting the quality requirements dictated by the market. EnviroCB is. “We are starting from a completely unique position compared to most other actors. At this point, Enviro has already provided industrial-quality recovered carbon black for rubber components in Volvo’s passenger cars for two years.” Thomas Sörensson notes. Several countries have even implemented or have plans to introduce manufacturer liability for waste categories that clearly impact the environment and society, not least tyres. This will generate even more awareness of Enviro’s recycling technology among industry actors around the world. Sörensson continues, “In addition to our recycled materials’ obvious environmental benefits, they’ve been demonstrated to be on a par with virgin carbon black across a wide range of applications and compounders. Considering that the global market for carbon black is estimated to exceed 25 billion dollars by 2020, the potential for both Enviro’s technology and our recycled materials is inarguable.” For more information, please contact:Thomas Sörensson, CEO of Enviro, tel: +46 (0)735-10 53 43, thomas.sorensson@envirosystems.se   Alf Blomqvist, Chairman of the Board, Enviro, tel: +46 (0)733 149 700, alf@blomqvistunlimited.com Scandinavian Enviro Systems AB Regnbågsgatan 8C 417 55 Gothenburginfo@envirosystems.se www.envirosystems.se

Linköping University Hospital second Swedish site in largest ever prospective multicenter clinical study for early detection of pancreatic cancer

LUND and LINKÖPING, SWEDEN― Immunovia AB today announced that Linköping University Hospital is to participate in PanFAM-1, the largest ever prospective study looking at early diagnosis in high-risk individuals with Familial Pancreatic Cancer (FPC). Designed to validate Immunovia ́s innovative blood test, IMMray™ PanCan-d, the study will analyze more than thousand individuals over three years across sites in Sweden, the US and Europe already offering FPC screening programs. The aim is to improve the outcome for the cancer patients and to prove the overall healthcare benefits of testing persons with heredity for pancreatic cancer. Parallel to this Immunovia is also running a study for another newly identified high risk group, new onset diabetics over 50 years of age . “We know from worldwide experience that early surgical intervention is essential in treating pancreatic cancer,” says Associate Professor Thomas Gasslander, Dept of Surgery, Linköping University Hospital. “Members of families with heredity for pancreatic cancer have an increased risk to develop pancreatic cancer, but so far we lack accurate, non-invasive early diagnostic tools. A test such as IMMray™ PanCan-d could be of great value in the surveillance of this group and therefore we are pleased to join the PanFAM-1 study along with other colleagues in Sweden, USA, UK and Spain.” “The entry of Linköping University Hospital to PanFAM-1 marks a major step forward as we aim to establish a national program for early detection of pancreatic cancer among major risk groups here in Sweden,” commented Mats Grahn, CEO, Immunovia. “It also strengthens the study’s overall reach across Europe and the US. We are on schedule to present interim results in 2019.” The other PanFAM-1 partners to date are: Mount Sinai, New York ; Knight Cancer Institute at Oregon Health and Sciences University, Portland, OR;  The University of Pittsburgh Medical Center Pittsburgh, PA ; The Massachusetts General Hospital, Boston, MA ; NYU School of Medicine, New York; The University of Liverpool, UK ; Ramon y Cajal Institute for Health Research Madrid, Spain ; University Hospital of Santiago de Compostela, Spain , Clínica Universidad de Navarra, Spain and Sahlgrenska University Hospital, Gothenburg, Sweden.  Advanced discussions over potential participation continue with several other European and US centers running high risk surveillance programs. For more information, please contact: Mats Grahn Chief Executive Officer, CEO, Immunovia Tel.: +46-70-5320230 Email: mats.grahn@immunovia.com  About ImmunoviaImmunovia AB was founded in 2007 by investigators from the Department of Immunotechnology at Lund University and CREATE Health, the Center for Translational Cancer Research in Lund, Sweden. Immunovia’s strategy is to decipher the wealth of information in blood and translate it into clinically useful tools to diagnose complex diseases such as cancer, earlier and more accurately than previously possible. Immunovia´s core technology platform, IMMray™, is based on antibody biomarker microarray analysis. The company is now performing clinical validation studies for the commercialization of IMMray™ PanCan-d that could be the first blood based test for early diagnosis of pancreatic cancer. In the beginning of 2016, the company started a program focused on autoimmune diseases diagnosis, prognosis and therapy monitoring. The first test from this program, IMMray™ SLE-d, is a biomarker signature derived for differential diagnosis of lupus, now undergoing evaluation and validation. (Source: www.immunovia.com) Immunovia’s shares (IMMNOV) are listed on Nasdaq Stockholm. For more information, please visit www.immunovia.com. About Pancreatic Cancer   Pancreatic Cancer is one of the most deadly and difficult to detect cancers, as the signs and symptoms are diffuse and similar to other diseases. There are more than 40,000 deaths and over 50,000 new cases diagnosed each year in the U.S. alone, and the five-year survival rate for pancreatic cancer is currently 5-8 %. It is predicted to become the second leading cause of cancer death by 2020. However, because resection is more successful in stage I/II, early diagnosis can significantly improve pancreatic cancer patients’ 5-year survival rates from 5-8 % to up to 49%. ### 

MTG’s Annual General Meeting 2018

MTG today announced that the Annual General Meeting which was held today in Stockholm, voted to support all of the resolutions that the Board and Nomination Committee proposed to the Meeting. The Annual General Meeting adopted the Income Statement and Balance Sheet, as well as the consolidated financial statements and the Auditor’s report on the consolidated financial statements for 2017. The Annual General Meeting discharged the board and the CEO from liability for 2017. The Annual General Meeting resolved to re-elect board members Joakim Andersson, David Chance, Simon Duffy, Donata Hopfen, John Lagerling and Natalie Tydeman and elect Gerhard Florin as new member of the board. The Annual General Meeting also re-elected David Chance as Chairman of the board. The Meeting approved the payment of an annual ordinary dividend of SEK 12.50 per share to shareholders at the record date of Thursday 24 May 2018. The dividend payment is expected to be made on Tuesday 29 May 2018. The Meeting resolved to approve the proposal for remuneration to the Board and auditor and the procedure for the Nomination Committee (to apply until a resolution regarding a change of the procedure for appointing the Nomination Committee is resolved by the general meeting). The Meeting resolved to approve the proposed guidelines for the remuneration to senior executives. The Meeting resolved to authorise the Board of Directors to pass a resolution on one or more occasions for the period up until the next Annual General Meeting to repurchase so many Class A and/or Class B shares that MTG’s holding does not at any time exceed 10 per cent of the total number of issued MTG shares. The Meeting also resolved to amend the provision in the Articles of Association regarding the auditor’s term of office, as well as editorial adjustments of the Articles of Association due to changed legislation, and re-elected KPMG as auditor until the close of the 2019 Annual General Meeting. Joakim Thilstedt will continue as auditor-in-charge. At a statutory meeting of the Board of Directors following the Meeting, the Audit and Remuneration Committees were appointed. Simon Duffy was appointed as Chairman of the Audit Committee, with Joakim Andersson, Donata Hopfen and Natalie Tydeman appointed as Committee members. Joakim Andersson was appointed as Chairman of the Remuneration Committee, with David Chance, John Lagerling and Gerhard Florin appointed as Committee members.  **** MTG (Modern Times Group MTG AB (publ.)) is a leading international digital entertainment group and we are shaping the future of entertainment by connecting consumers with the content that they love in as many ways as possible. Our brands span TV, radio and next generation entertainment experiences in esports, digital video content and online gaming. Born in Sweden, our shares are listed on Nasdaq Stockholm (‘MTGA’ and ‘MTGB’). Contact us:press@mtg.com (or Tobias Gyhlénius, Head of Public Relations; +46 73 699 27 09)investors@mtg.com (or Stefan Lycke, Head of Investor Relations; +46 73 699 27 14)Download high-resolution photos: Flickr Follow us:mtg.com  / Facebook  / Twitter  / LinkedIn  / Instagram  / YouTube 

MTG increases ownership in global online video publisher Zoomin.TV

MTG has increased its ownership in Zoom.in Group B.V. (Zoomin.TV) from 51% to 100% by acquiring the remaining 49% of the company from Adversa Media Groep B.V., controlled by the current CEO and CFO of Zoomin.TV, who founded the company. MTG is paying a cash consideration of EUR 6.2 million for the shares and is also settling Adversa’s EUR 11.3 million of shareholder loans to Zoomin.TV. Zoomin.TV is a leading global publisher of online video content targeting Generation Z viewers. Headquartered in Amsterdam and with 16 offices on four continents, Zoomin.TV’s global network of 3,500 freelance video journalists produces digital video content that generates around 3.2 billion views every month. Zoomin.TV was one of the content providers chosen to support the launch of the Facebook Watch video platform in 2017 , and has also signed a partnership with Tencent  to bring Zoomin.TV’s content to viewers in China. Jørgen Madsen Lindemann, MTG President & CEO: “Every day, Zoomin.TV delivers hundreds of videos from around the world that inspire Generation Z. These unique stories have made the company one of the world’s largest online video publishers, and now we will work more closely with Zoomin.TV to reach even more of the world’s most passionate audiences.” MTG acquired 51% of Zoomin.TV in July 2015 from Adversa and Evalue AG, and the consideration for the remaining shares is in accordance with the previous agreements with Adversa. The transaction will result in a preliminary non-cash net gain of approximately EUR 3 million, which will be reported within items affecting comparability in MTG’s Q2 2018 financial results. ****  NOTES TO EDITORS MTG (Modern Times Group MTG AB (publ)) is a leading international digital entertainment group and we are shaping the future of entertainment by connecting consumers with the content that they love in as many ways as possible. Our brands span TV, radio and next generation entertainment experiences in esports, digital video content and online gaming. Born in Sweden, our shares are listed on Nasdaq Stockholm (‘MTGA’ and ‘MTGB’). Contact us:press@mtg.com (or Tobias Gyhlénius, Head of Public Relations; +46 73 699 27 09)investors@mtg.com (or Stefan Lycke, Head of Investor Relations; +46 73 699 27 14) Download high-resolution photos: Flickr Follow us:mtg.com  / Facebook  / Twitter  / LinkedIn  / Instagram  / YouTube 

Nitro Games announced new game Heroes of Warland

“We are thrilled to announce Heroes of Warland. Our team is taking competitive multiplayer on mobile to a new level with this game. There’s a good market opportunity for a team based competitive multiplayer game on mobile right now. Our hero based class system is a unique new thing in the emerging shooter genre on mobile and helps us to build better team gameplay.” says Jussi Tähtinen, CEO & Co-Founder, Nitro Games Oyj. This launch follows Nitro Games’ strategy where the company is building a portfolio of games to be self-published in the western markets and accessing other markets via publishing partners. Heroes of Warland is the second game in Nitro Games’ new portfolio, following Medals of War that was introduced last year. It has been developed with Nitro Games’ MVP –process, where the game development is closely tied to continuously collecting actual market data and community feedback, as the game is being further developed. This announcement is the first step in the game launch in western markets. After this announcement, the game will soon enter the so-called public soft launch in selected markets. The commercial hard launch is targeted for 2018 after the soft launch. Heroes of Warland is a team-based competitive multiplayer game on mobile. With Heroes of Warland, Nitro Games is introducing hero-based shooter game on mobile for the first time. This genre has been highly popular on PC. Hero-based shooter means that the game has several hero characters, each with own unique skills and abilities, offering a unique and fun team multiplayer experience previously unseen on mobile. Find out more: https://youtu.be/nkYlAO8Gy_8 www.heroesofwarland.com

Mr Green gives guidance for 2018 and communicates new financial targets at its Capital Markets Day

Today, at its Capital Markets Day, Mr Green guides on an expected revenue growth of at least 40 per cent for 2018 with an EBITDA margin of about 15 per cent. The Group is as of today called MRG and has a new brand profile to reflect the profile as a high growth digital Group. In the period 1 April–22 May, MRG’s revenue has increased by over 40 per cent compared with the same period 2017. Customer deposits has increased by more than 60 per cent in the same period. According to MRG’s new financial targets, the Group is expected to achieve annual growth of 25 per cent by 2020. Thereafter, MRG is expecting annual organic growth above the European iGaming market. The EBITDA margin is expected to be 15 per cent 2020 and going forward. Previous financial targets said that an annual growth of 20 per cent for 2018–2019 with an EBITDA margin of 20 per cent by 2019 was expected. After 2019, growth above the online gaming market with an EBITDA margin of 15 per cent was expected, under the assumption of 100 per cent regulated markets. Unchanged dividend policy The dividend policy is unchanged, saying that the aim is to pay a dividend and/or repurchase shares in an amount of up to 50 per cent of consolidated free cash flow unless it is deemed that the Group’s liquid assets are needed to realise the Company’s strategy, future tax payments or need to be set aside to secure additional reserves when warranted by conditions in capitals markets. New ventures in development of games and esports At the Capital Markets Day, MRG will tell about its new ventures in proprietary games and esports. The development of games is run in the wholly owned subsidiary Green Jade Games and esports is a joint venture with Gamingzone Entertainment. Mr Green becomes MRG As of today, the Mr Green Group will be called MRG and has a new brand profile. The domain is changed to mrggroup.com . ”MRG is a digital, high growth company with a significantly broader operation with more brands and larger geographical presence than a year ago”, says Per Norman, CEO of MRG. “We invest in new innovative digital areas within iGaming and esports. MRG is reflecting our vision ‘Shape the future of the iGaming industry’.” Agenda Capital Markets Day Strategy 2020 Per Norman, CEO MRGOperator business Jesper Kärrbrink, CEO Mr Green LtdGrowth and marketing Magnus Alebo, MD Mr GreenefficiencyThe Evoke Gaming Fredrik Staël von Holstein, MD Evoke GamingturnaroundOperations and product Antoine Bonello, COO Mr Green LtdProvider of world Mattias Wedar, CEO MRG Gametekclass technologysolutionsPeople & Culture Roberta Geres, Chief HR Officer Mr Green LtdEsports Henrik Stridsman, Customer AdvocateGreen Jade Games Ben McDonagh, CEO Green Jade GamesRegulatory update Jan Tjernell, General Counsel MRGGuidance 2018 and Simon Falk, CFO MRGfinancial targets The Capital Markets Day takes place today at 01:00p.m.-05:00p.m. CET at Epicenter, Stockholm. To watch the Capital Markets Day live, go to mrggroup.com  or financialhearings.com . For further information, please contact:Per Norman, CEO MRG, tel. +46 72 230 91 91, per.norman@mrggroup.com Åse Lindskog, Director Communications and IR, tel. +46 730 24 48 72, ase.lindskog@mrggroup.com This information is information that MRG (Mr Green & Co AB) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 23 May 2018 at 08:20a.m. CET. MRG is a fast-growing, innovative iGaming Group with operations in twelve markets. MRG offers a superior experience in a Green Gaming environment. MRG was founded in 2007 and operates the iGaming sites Mr Green, Redbet, Vinnarum Casino, Bertil, MamaMia Casino, BingoSjov and BingoSlottet. The Group had a turnover of SEK 1,192.0 million in 2017 and has over 300 employees. MRG has gaming licenses in Malta, UK, Italy, casino license in Denmark and Sportsbook license in Ireland. MRG is, through its parent company Mr Green & Co, listed on Nasdaq Stockholm in the Mid Cap segment. Read more at www.mrggroup.com.

Vattenfall and Facebook sign long-term deals for new Nordic renewable energy

Vattenfall has been awarded a contract from Facebook to provide wind integration and balancing services for the three new wind projects of the Bjerkreim cluster located in southwest Norway. Facebook has purchased 100% of the output of the 294 MW cluster under long-term power purchase agreements with the wind farm owner Luxcara. Vattenfall will also be the selected electricity supplier to Facebook’s data centre facilities in Odense and Luleå. “Vattenfall is very proud to have expanded its long-term cooperation with Facebook to include integrating their supply of new renewable energy into the Nordic electric grid. The balancing services agreement is Vattenfall’s largest agreement with an external partner in the Nordics,” said Branislav Slavic, Vice President of Business Sales Nordic at Vattenfall. “We are excited to partner with Vattenfall on our largest European renewable project to date. These projects will add wind energy to the Nordic grid providing a 100% renewable solution to our data center campuses in Odense, Denmark and Luleå, Sweden,” said Vince Van Son, Facebook’s Commercial Director for Energy and Infrastructure. "It will also provide a renewable solution for the electricity consumed at the energy center in Odense, enabling the production of renewable heating for the community from the heat recovered at our data centre.” For more information, contact:  Vattenfall Press Office +46 8 739 5010, press@vattenfall.com

Invitation to Autoliv and Veoneer Investor Day webcast and telephone conference

Autoliv, Inc. will host two Investor Days: one on May 31, 2018, in Stockholm, Sweden, and one on June 4, 2018, in New York, US. The Investor Day in Stockholm will be webcast on www.autoliv.com between 9:00-15:30 CET. There is also a possibility to phone into the telephone conference: United Kingdom (national free phone): 0800 279 7204        United States /Canada (national free phone): 800-289-0571 Sweden (national free phone): 0200 883 464                                           International Call: +44 (0)330 336 9411                                                                              Confirmation Code: 4219973                       Webcast details, the agenda and presentations will be available on the website www.autoliv.com the morning of May 31. The intention is to publish a press release ahead of the start of the Investor Day. Shortly after the conference, an audio replay and a transcript will be available on our website. These will remain available for a period of one year. Inquiries: Media: Thomas Jönsson, Corporate Communications, tel +46 (0)8 5872 0627 Investors & Analysts, Anders Trapp, Investor Relations, tel +46 (0)8 58 72 06 71 Investors & Analysts, Ray Pekar, Investor Relations, tel +1 (248) 794 4537 About Autoliv Autoliv, Inc. is the worldwide leader in automotive safety systems, and through its subsidiaries develops and manufactures automotive safety systems for all major automotive manufacturers in the world. Together with its joint ventures, Autoliv has more than 72,000 employees in 27 countries. In addition, the Company has 23 technical centers in nine countries around the world, with 19 test tracks, more than any other automotive safety supplier. Sales in 2017 amounted to about US $10.4 billion. The Company’s shares are listed on the New York Stock Exchange (NYSE: ALV) and its Swedish Depository Receipts on Nasdaq Stockholm (ALIV sdb). For more information about Autoliv, please visit our company website at www.autoliv.com. Safe Harbor Statement This release contains statements that are not historical facts but rather forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those that address activities, events or developments that Autoliv, Inc. or its management believes or anticipates may occur in the future, including those related to the timing of the investor and analyst days, the intended spin-off and the expected performance of Autoliv and Veoneer following completion of the spin-off. All forward-looking statements are based upon our current expectations, various assumptions and/or data available from third parties. Our expectations and assumptions are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties and other factors which may cause actual future results, performance or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements. Numerous risks, uncertainties and other factors may cause actual results to differ materially from those set out in the forward-looking statements, including general economic conditions and fluctuations in the global automotive market. For any forward-looking statements contained in this or any other document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we assume no obligation to update publicly or revise any forward-looking statements in light of new information or future events, except as required by law.

Episurf Medical continues preparations for its US IDE study by appointing Dr Michael A Kelly as special study advisor

Episurf Medical (NASDAQ: EPIS B) is approaching the filing of its application to conduct an IDE study in the US. As an important step in the design and structuring of the study, the company appoints Dr Michael A Kelly as special study advisor. Dr Kelly will work with Episurf Medical and advise the company on a broad range of topics related to its IDE study and US launch. Dr Michael A Kelly is the Chairman of the Department of Orthopaedic Surgery at The Hackensack University Medical Center in New Jersey and was previously President of the prestigious American Knee Society. He is the founding Professor and Chairman for Orthopedic Surgery at Hackensack Meridian School of Medicine at Seton Hall University. Dr Kelly’s practice is focused on all aspects of knee surgery and he is the author of numerous scientific articles within the field. He co-edited the textbook Surgery of the Knee 2nd Edition. Dr Kelly has lectured throughout the U.S. and internationally on topics related to sports medicine and knee reconstruction and he is a member of many professional organizations, including the American Orthopaedic Society of Sports Medicine and the American Orthopaedic Association. Previously, Dr Kelly served as the head team physician of the New Jersey Nets in the NBA (National Basketball Association). Dr Kelly is a graduate from Georgetown University School of Medicine. ”I am looking forward to working with Episurf Medical, as treatment of this patient group is a challenge for the orthopaedic industry” says Dr Michael A Kelly. “The feedback from orthopaedic surgeons in the US has been highly encouraging, and we are proud to have Dr Kelly as an advisor to Episurf Medical in this very important strategic initiative” says Pål Ryfors, CEO of Episurf Medical. For more  information, please contact: Pål Ryfors, CEO, Episurf Medical Tel:+46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalised treatment alternatives. Episurf Medical’s Episealer® personalised implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com. This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.30 CEST on 23 May 2018.

E.ON, H&M group, Scania and Siemens form a coalition to accelerate decarbonisation of heavy transport

The starting point for the coalition is The Pathways Study: Achieving fossil-free commercial transport by 2050 . The study concludes that fossil-free commercial transport in the timeframe of the Paris agreement target, is definitely possible. However, to get there industry and the political arena must come together, initiate immediate change and ensure action at an unprecedented rate. Industry players are therefore joining together as one voice to impact public opinion and policy with the aim to establish an optimal environment for mutually beneficial change in the transport sector. A systems approach will be required, and the coalition of companies forms a strong foundation with representatives from infrastructure provision, energy solutions and supply, vehicle manufacturing as well as retail with the transport buyer perspective. The coalition of companies will continue to build knowledge, and identify high impact innovation and partnerships within their operations and respective ecosystems. “The past years have shown that the shift to sustainable commercial transport is gathering pace and the market is responding. However, much more must be done to offset the impact of greenhouse gas emissions. No one can do this alone, but through cooperation we can succeed. That is why the foundation that we are laying with this coalition of the willing is a very important step that demonstrates how we will be driving change,” says Henrik Henriksson, Scania’s President and CEO. “What we are announcing today is a stepping stone for further and deeper knowledge about the global decarbonisation of heavy commercial transport. However, it is already now clear that infrastructure for electrification of heavy vehicles is a key part of this journey. It is therefore a very good fit for Siemens to join the group of companies willing to influence and committed to making this happen,” says Ulf Troedsson, President and CEO of Siemens Nordics “There is no doubt that green energy will power the transport system of the future. The transformation of the heavy commercial transport sector impacts a full ecosystem of players. When we look at our long-term agendas, we are aligned, but it is now that we need to join forces to catalyse change. This is only the first step in a very interesting collaboration,” says Marc Hoffmann CEO of E.ON Sweden. “Climate is one of the most important priorities for any company today and we have set high ambitions for our business to become climate positive by 2040. But it is only when we join forces with other key players in the industry that we can achieve ambitious goals. Joining this coalition will give us a unique position to implement smart, efficient and sustainable solutions for our transport and logistics,” says Anna Gedda, Head of Sustainability H&M group. For further information, please contact: Karin Hallstan, Public Relations Manager, Scania, phone: +46 76 842 81 04,e-mail: karin.hallstan@scania.com Charlotta Målargård, Head of Communications, Siemens AB,phone: +4670-728 10 67; e-mail: charlotta.malargard@siemens.com Pernilla Schoug, E.ON Sweden +4670 655 14 85 H&M group Media Relations: groupmediarelations@hm.com

Nordstjernan accepts bid for Norwegian listed furniture Group Ekornes

The investment company Nordstjernan AB (“Nordstjernan”) has through pre-acceptance confirmed that the company is divesting its holding in the Norwegian listed furniture Group Ekornes ASA (“Ekornes”). This is provided that the transaction entered into today between Ekornes and a Chinese consortium, headed by the Chinese furniture company Qumei Home Furnishings Group Co. Ltd. (“Qumei”), is completed. Nordstjernan owns 6,359,652 shares in Ekornes, corresponding to 17.2 percent of capital and voting rights in the company. Ekornes was established in 1934 and Nordstjernan has been the largest shareholder in Ekornes since 2008. “Ekornes is a first-rate company, and owns one of the world’s strongest furniture brands – Stressless®. The company’s management and Board of Directors has been highly successful in recent years, rationalizing costs and acquiring the Southeast Asia-based furniture company IMG. In the next phase, I believe Qumei can create new growth opportunities and represents a good option as a new industrial owner of the company. I also consider the bid of NOK 139 per share attractive. If the bid is accepted, this means, together with the dividend paid of NOK 31, returns over the past 24 months have totaled 85 percent excluding the reinvestment of dividends. Because we consider the bid attractive, both for Ekornes and its shareholders, Nordstjernan has decided to support the pre-acceptance,” says Tomas Billing, CEO of Nordstjernan.Tomas BillingPresident and CEONordstjernan ABQuestions will be answered by: Tomas Billing, CEO of NordstjernanTelephone: +46 8 788 50 18E-mail: tomas.billing@nordstjernan.se Nordstjernan AB is a family-controlled investment company whose business concept is to be an active owner that creates long-term and positive value growth. More information about Nordstjernan can be found on www.nordstjernan.se.

MRG establishes operations in the Baltics by the acquisition of the iGaming operator 11.lv

As part of its strategy to establish operations in the Baltics, MRG has signed an agreement to acquire a majority of the Latvian gaming operator 11.lv. The Baltics – Estonia, Latvia and Lithuania – is regulated across all countries with national regulations and licensing systems. The region is characterized by robust growth for iGaming. The Baltic market for iGaming grew by 45 per cent in 2017. ”This is a major step in our strategy to expand into locally regulated markets”, says Per Norman, CEO of MRG. “We foresee excellent growth opportunities for our strong Mr Green and Redbet brands also in the Baltics.” 11.lv is a well-known Latvian iGaming brand with a focus on Sportsbook and the third largest iGaming operator in Latvia. The company has a gaming license in Latvia and offers betting, casino and live casino. Revenues amounted to EUR 944 k in Q118 and EBITDA was EUR 162 k. The revenue growth was 44 per cent from Q117. MRG acquires 75 per cent of the shares. Two of the founders, who stay in the company, keep 25 per cent of the shares. The purchase price amounts to EUR 2.8 million based on an enterprise value of EUR 3.7 million. The purchase price is paid in cash. The price is calculated on enterprise value (debt free basis). 11.lv has 15 employees, all based in Riga, Latvia. “11.lv has a strong brand recognition in Latvia and will be the base for our expansion in the Baltics”, continues Per Norman. “Our first step is to launch Mr Green in Latvia which, together with 11.lv, give us a broad, attractive offering for the Baltic market.” For further information, please contact:Per Norman, CEO MRG, tel. +46 72 230 91 91, per.norman@mrggroup.com Åse Lindskog, Director Communications and IR, tel. +46 730 24 48 72, ase.lindskog@mrggroup.com MRG is a fast-growing, innovative iGaming Group with operations in twelve markets. MRG offers a superior experience in a Green Gaming environment. MRG was founded in 2007 and operates the iGaming sites Mr Green, Redbet, Vinnarum Casino, Bertil, MamaMia Casino, BingoSjov and BingoSlottet. The Group had a turnover of SEK 1,192.0 million in 2017 and has over 300 employees. MRG has gaming licenses in Malta, UK, Italy, casino license in Denmark and Sportsbook license in Ireland. MRG is, through its parent company Mr Green & Co, listed on Nasdaq Stockholm in the Mid Cap segment. Read more at www.mrggroup.com.

CEO statement on the Nordic Prime Minister’s Letter of Intent on the Development of 5G in the Nordic countries

As CEOs of the leading Nordic telecommunication companies, we welcome the letter of intent on 5G development signed today by the leaders of Nordic countries. A vision for a common Nordic 5G space agreed today confirms our region’s ambition to remain a leading digitalized and innovation region to the benefit of our societies. The challenge ahead is to make this vision a practical reality. We welcome in particular the recognition by the leaders that the deployment of 5G will require substantial investments as well as the appropriate regulatory frameworks. Swift elaboration of specific, measurable and time-bound actions to facilitate 5G deployment eco-systems will be crucial to create the right conditions for private investment – the foundation of 5G roll-out. Appropriate spectrum assignment rules and removing obstacles to the deployment of 5G infrastructure should be at the center of such action plan. We look forward to actively collaborating with the Ministers of Digitalization and Ministers responsible for the key sectors identified as well as other stakeholders on the follow-up to the letter of intent.Signatories:Börje Ekholm, President and CEO, EricssonRajeev Suri, President and CEO, NokiaPernille Erenbjerg, President and CEO, TDC GroupAllison Kirkby, President and CEO, Tele2 GroupSigve Brekke, President and CEO, Telenor GroupJohan Dennelind, President and CEO, Telia CompanyStefán Sigurðsson, CEO, Vodafone Iceland For more information, please contact:Viktor Wallström, EVP Group Communications, Tele2 AB, Phone: +46 703 63 53 27Erik Strandin Pers, Head of Investor Relations, Tele2 AB, Phone: +46 733 41 41 88

"Proving the Business Model for Sponsored Network Slices" Wins Catalyst Award at Digital Transformation World 2018

"Proving the Business Model for Sponsored Network Slices" Wins Catalyst Award at Digital Transformation World 2018 TM Forum’s award recognizes the Catalyst teams who have demonstrated outstanding work in solving real-world challenges or making future opportunities a reality PRESS RELEASE - FOR IMMEDIATE RELEASE Helsinki, Finland, and Nice, France, May 23, 2018— Cloudstreet, The Network Slicing Company  today announced that its Catalyst project “Proving the Business Model for Sponsored Network Slices: Mobile Gaming”  has been selected as a winner  in TM Forum’s 2018 Catalyst Awards at Digital Transformation World  in Nice. Championed by Orange  and NTT , the Sponsored Network Slices Project was recognized for the Outstanding Catalyst Business Impact Award, providing the Forum’s very strongest validation of the business concept and blueprint for its deployment. Cloudstreet, provider of the project’s Network Slicing platform and business logic was joined by OSS/BSS-focused Catalyst participants including Nokia , Cerillion  and Sigma Systems .  Catalysts  are member-driven proof-of-concept projects which connect diverse organizations to develop innovative, commercially viable prototypes of new digital services and business models. Twice per year, TM Forum recognizes the Catalyst teams who have demonstrated outstanding work in developing solutions to the challenges that the industry is facing. The 7 winning programs were selected from 24 Catalysts, all of which were showcased at this year’s Digital Transformation World.   “The Catalyst projects showcased at Digital Transformation World 2018 were incredibly innovative and demonstrated real solutions to industry challenges,” said Andy Tiller, EVP Collaboration and Innovation, TM Forum. “Catalysts showcase the power of collaboration enabled by TM Forum, and bring together a wide range of companies, industries and ecosystems. Our sincere congratulations to the winners and to all those who participated for their outstanding work.” “We are deeply honoured to have been recognized with this prestigious award, not only for the hard work it represents, but for the strong validation it provides for our unique approach to monetizing Network Slicing,” said Mika Skarp, Founder and CTO of Cloudstreet. “As Network Slicing moves quickly toward global commercialization amoung leading operators, we believe that the combination of our technology and carrier-friendly approach will echo the important business impacts recognized by the TM Forum and much anticipated for the mobile industry at large.” More than 100 member companies and hundreds of individuals participated in the 2018 Catalyst projects, which spanned Open APIs, SDN & NFV, digital health, data monetization, AI, blockchain, smart cities, the Internet of Everything and more. The winners of the 2018 Catalyst Awards were judged by TM Forum’s Collaboration Sub-Committee, which oversees the effective creation and adoption of pragmatic best practices and standards, delivering value to the membership by meeting industry needs. -30-

Management Changes at BioGaia

Axel Sjöblad was appointed as Managing Director effective March 1, 2016 and has successfully focused on further expanding BioGaias sales capabilities. ”I am proud of the progress that has taken place at the company during my time at BioGaia. Now the company is entering into the next phase with greater focus on consumer marketing and advanced research including the microbiome field. I have therefore agreed with the Board to resign as Managing Director”, says Axel Sjöblad. The search for a new Managing Director has commenced. The Board of BioGaia has appointed Sebastian Schröder as Acting Managing Director until such time that a new Managing Director is appointed. Thereafter Sebastian Schröder will take on the position as Executive Vice president Strategy and Business Development. Sebastian Schröder originally joined BioGaia in 2003 and left the company in 2006 to pursue new challenges. He was recruited back to BioGaia in 2015 to lead the Strategy and Business Development functions. ”We thank Axel Sjöblad for his successful efforts including record sales, geographic expansion and the further introduction of our products in existing markets” says Peter Rothschild, Chairman of BioGaia. This information is information that BioGaia AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 23 May 2018, at 13:00 CET. Latest press releases from BioGaia2018-05-22 BioGaia signs exclusive agreement in Mongolia2018-04-26 Annual General Meeting of BioGaia2018-04-25 BioGaia AB – Interim management statement 1 January – 31 March 2018 

Delete to acquire Karhupurku Oy specialising in elevator dismantling – the Demolition Services business area expands to cover elevator dismantling

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. According to a contract signed on 23 May 2018, environmental full-service provider Delete Group Oyj will acquire Karhupurku Oy that specialises in the dismantling of elevators. The acquisition is planned to take place on 31 May 2018. This strategic acquisition aims to strengthen Delete’s position as the leading provider of environmental services and largest demolition contractor in the Nordic countries.  Karhupurku Oy, established in 2015, has gained a strong foothold in the dismantling of elevators in southwestern Finland. Before its establishment, Karhupurku Oy operated as part of Ovitek Oy for almost 10 years.  Delete’s CEO Tommi Kajasoja  “This acquisition supports our strategic growth as a leading Nordic provider of environmental services and the largest demolition contractor. The acquisition introduces a new and strong business area with growth potential for Delete in our Demolition Services business area in connection with elevator dismantling. It also completes Delete’s demolition offering and gains synergy from the existing Delete’s Demolition and Recycling Services business areas. The acquisition provides a significant opportunity for Delete to expand into the dismantling of elevators nationally in Finland and also expand it in other Nordic countries in the future.” As a result of over 30 successful acquisitions and organic growth in Finland and Sweden, Delete is currently the leading provider of environmental services and the largest demolition contractor. The future outlook of elevator dismantling is supported by the growth in construction, ageing property stock, ageing population and digitalisation.  Through the acquisition, seven new demolition professionals will join Delete’s team. The effect on Delete’s result of 2018 is minor. In 2017, Karhupurku’s net sales were EUR 0.6 million. The parties have agreed not to disclose the acquisition price.  DELETE GROUP OYJ  Further information:  Ville Mannola, CFO tel. +358 400 357 767 e-mail: ville.mannola@delete.fi  DISTRIBUTION: Nasdaq Helsinki Ltd Main media https://deletegroup.fi/en/

Record day for free warrants of series TO4B as well as information about period for exercising warrants of series TO4B

One (1) warrant of series TO4B is granted for 27 existing shares held by the shareholder on the record date 30th May 2018, rounded downwards.Each warrant entitles the holder to subscribe for one (1) new Episurf share at a fixed strike price of SEK 6.10 during the periods below.Subscription of new shares through the exercise of warrants of series TO4B for a total value of SEK 500,000 or more may take place from the registration date of the decision to issue the warrants at the Swedish Companies Registration Office until the last day of five (5) years after the registration date at the Swedish Companies Registration Office. The issue of warrants of series TO4B was registered at the Swedish Companies Registration Office on Wednesday, 23rd May  2018. The exercise of warrants below an aggregated amount of SEK 500,000 may take place on ten occasions during the two-week period preceding the day of 6, 12, 18, 24, 30, 36, 42, 48, 54 and 60 months after the date on which the warrants are registered at the Swedish Companies Registration Office, 23 May 2018. Subscription of shares based on warrants of series TO4B will subsequently be possible during the following periods:- Thursday, May 9, 2019 until Thursday, May 23, 2019- Saturday November 9, 2019 until Saturday, November 23, 2019- Saturday, May 9, 2020 until Saturday, May 23, 2020- Monday, November 9, 2020 until Monday, November 23, 2020- Sunday, May 9, 2021 until Sunday, May 23, 2021- Tuesday, November 9, 2021 until Tuesday, November 23, 2021- Monday, May 9, 2022 until Monday, May 23, 2022- Wednesday November 9, 2022 until Wednesday, November 23, 2022- Tuesday, May 9, 2023 until Tuesday, May 23, 2023- Thursday, November 9, 2023 until Thursday, November 23, 2023The warrants are available from 2018-06-01. This is executed automatically via Euroclear, which manages the company's share register. For more  information, please contact: Pål Ryfors, CEO, Episurf Medical Tel:+46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalised treatment alternatives. Episurf Medical’s Episealer® personalised implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

Catella: Demand pressure in European commercial residential markets – yield decreases aren’t measured

In the 19 countries analyzed by Catella, a total transaction volume of EUR 48.1 billion was achieved in 2017. 32% of this was achieved in Germany alone, followed by UK with a share of 15%. The taillight in this ranking is Belgium with merely EUR 55.8 million. Further single results of this analysis: - The lowest yield of all European residential markets can be found in Stockholm with 1.50%, followed by Zurich with 2.20%. The highest yield can be found in Krakow with 7.44%, followed by Warsaw with 6.15%. The average European yield is at 3.97%. - The lowest average rent is in Vilnius with 8.75 €/sqm, closely followed by Riga with 9.25 €/sqm. The most expensive rental flats by far are found in London with average prices of 40.78 €/sqm. Behind that, the continental city of Bern follows with 34.10 €/sqm. The average price of the 54 presented rental prices in Europe is at 15.21 €/sqm. - The city of Vilnius has the lowest purchase prices for owner-occupied flats with an average of 1,470 €/sqm. The second lowest city is Wroclaw with 1,520 €/sqm. The most expensive prices per square meter for owner-occupied flats are also paid in London with 16,935 €/sqm. Zurich is in second place with 1,007 €/sqm and therefore ahead of Paris, where the average price is 10,030 €/sqm.   “The demand pressure in the European commercial residential markets will sustain. In 31 of 59 cities, a slight decline of yields is expected by the end of the year, while increasing yields aren’t expected in any European city”, explains Dr. Thomas Beyerle, Head of Group Research at Catella. “For investors, the Polish cities seem to have the most attractive yields”, Beyerle continues. The full analysis is available at catella.com/research.   For information please contact:Dr Thomas BeyerleHead of Group Research+49 69 3101 9302 20thomas.beyerle@catella.de    Catella is a leading specialist in property investments, fund management and banking, with operations in 14 European countries. The group has sales of approximately EUR 211 million and manages assets of approximately EUR 16 billion. Catella is listed on Nasdaq Stockholm in the Mid Cap segment. Read more at catella.com .

InCoax enters into Letter of Intent with Swiss cable operator

The LOI stipulates that the purchase order to be formalized for InCoax products to evaluate, regards 10 units of Coax Link Controller, including the Coax Link Management system, and 100 units of Coax Access Modem, all based on the MoCA Access™ 2.5 specification. The InCoax products will be evaluated in multi-dwelling units (apartments) as part of joint field trials planned to start in July 2018. This Swiss cable operator represents a typical use case: A cable operator using DOCSIS 3.0 to deliver cable-TV to customer apartments and that wants to upgrade its broadband offering to customers, and choses to do this much more cost effectively with InCoax’s products and solution based on MoCA Access™ 2.5, than upgrading to DOCSIS 3.1. This use case is common in both Switzerland and other countries. In addition, during April 2018, InCoax organized two workshops in Switzerland with more than 20 operators participating. The outcome was positive, with good interest from participants. According to Analysys Mason, a global consultancy and research firm specialising in telecoms, media and technology, the Swiss market has approximately 2.3 million apartments, whereof 1.2 million with active subscriptions over coax, and the estimated potential addressable market for MoCA based solutions, such as InCoax new generation products, is 1.0 million apartments. This represents a great opportunity for InCoax. “Based on what has unfolded recently in Switzerland, I have a very positive outlook for the potential development in the Swiss market and for this use case in other countries as well”, says Peter Carlsson, CEO of InCoax.

IRLAB Therapeutics has raised SEK 138.6 million in a directed share issue to top tier investors in the US and Sweden

“We are proud to have attracted a top tier US health care investor, three Swedish pension funds and highly renowned Swedish investors, all with deep knowledge of the pharmaceutical sector. It highlights the potential in our research platform and in our clinical programs. This is a milestone for IRLAB and provides even better conditions for us to continue to develop safe and effective treatments for unmet needs in Parkinson’s disease and other disorders of the brain”, comments Nicholas Waters, CEO of IRLAB Therapeutics. Background and motives The objectives of the share issue are to diversify the shareholder base in the company with renowned and sector specialised institutional and international investors, and, in a timely and cost-efficient manner, raise capital to fund the continued development of the company’s project portfolio. The share issue The Board of Directors has, based on the authorization granted by the Annual General Meeting on 16 May 2018, resolved on a directed share issue of 1,100,000 ordinary shares of series A. The subscription price in the issue is SEK 126 per share, which, in total, will raise SEK 138.6 million to the company before transaction costs. The subscription price for the issue has been determined through a so-called private placement procedure and represents a discount of 4.9 per cent compared to the volume weighted average share price during the last 30 trading days. The directed issue is fully subscribed by a number of selected institutional and international investors in accordance with separate agreements. The reasons for deviating from the shareholders’ preferential rights are primarily to diversify the shareholder base and, in a timely and cost-efficient manner, raise capital to fund the continued development of the company’s project portfolio. Through the issue, the share capital will increase with SEK 110,000 to SEK 809,993.9, which entails a dilution effect of approximately 13.6 per cent of both the number of shares and votes. Advisors IRLAB Therapeutics has, in connection with the transaction, engaged Advokatfirman Vinge as legal advisors and Erik Penser as settlement agent. Zonda Partners and MAQS Advokatbyrå have been engaged as advisors to the Board of Directors.

Panoro Energy Announces First Quarter 2018 Results and Provides Operations and Corporate Updates

Oslo, May 24, 2018 - Panoro Energy (the “Company” or “Panoro” with OSE ticker: “PEN”) today announces the first quarter 2018 financial results and provides the following highlights: Dussafu · Updated independent reserves report prepared by Netherland Sewell & Associates Inc. (“NSAI”) estimates gross Proved + Probable (2P) reserves of 23.5 MMboe and Contingent (2C) resources of 11.6 MMboe · First development well, DTM-2H, completed successfully in April; second development well, DTM-3H underway · Success at DTM-3 Appraisal well which encountered 30 metres of oil in the Gamba in the western flank of Tortue · First oil expected in 2H 2018 at an anticipated gross rate of 10,000 to 15,000 bopd (Operator estimate) Aje · AGR TRACS certified total gross Proved + Probable (2P) reserves at Aje of 127 Mmboe, which represents a substantial increase in 2P reserves compared to the last independent report provided in 2014 · Legal dispute with JV partners in relation to drilling of new development wells fully resolved through a mutually beneficial out-of-court settlement · Current oil production operations continue; focus on advancing the Turonian gas development plan and licence extension Corporate · Cash and cash equivalents of USD 5.1 million as at March 31, 2018, not including USD 1.5 million of cash which was refunded to the Company with accumulated interest post-period-end following the settlement of the Aje dispute Mr. John Hamilton, CEO of Panoro, commented: “We are very pleased with the recent operational successes at Dussafu and remain focused on unlocking its potential. We look forward to the upcoming drilling news flow, and delivering first oil in this higher oil price environment. In the meantime, we continue planning the next phases of development at both Aje and Dussafu. The next several months hold exciting and material milestones for Panoro and its shareholders.” Panoro will hold a conference call today at 08:30 a.m. CET, during which the Company will discuss the first quarter 2018 results. Participants are invited to ask questions about the second quarter report following the discussion. Participants are asked to dial-in five to ten minutes prior to the start time using the number and password below:  Local - Oslo, Norway +47 21 563 318Toll Free – Norway 800 19 457Local – New York, USA                        +1 212 999 6659Toll Free – USA +1 866 966 5335Local – London, UK +44 (0) 20 3003 2666Toll Free – UK 0808 109 0700Password: Panoro Energy For further information please contact: Qazi Qadeer, Chief Financial OfficerTel:     +44 203 405 1060Email: info@panoroenergy.com About Panoro Energy  Panoro Energy ASA is an independent E&P company based in London and listed on the Oslo Stock Exchange with ticker PEN. The Company holds production, exploration and development assets in West Africa, namely the Dussafu License offshore southern Gabon, and OML 113 offshore western Nigeria. In addition to discovered hydrocarbon resources and reserves, both assets also hold significant exploration potential. For more information, please visit the Company’s website at www.panoroenergy.com.

EnQuest PLC Announces Operations update

 24 May 2018 2018 highlights * Group production in line with expectations, averaging 56,077 Boepd in the four months to end April 2018, up 48.1% on the same period in 2017; full year 2018 guidance of 50,000 Boepd to 58,000 Boepd reaffirmed    - Kraken average gross production has been over 36,000 Bopd in the period, excluding the March maintenance shutdown    - Heather H-67 well completed and onstream in March with production significantly better than expectations; Magnus M-62 well completed and onstream in May    -  Drilling at PM8/Seligi is now underway; on track to complete two wells by Q3 * At 30 April 2018, cash and available bank facilities amounted to $204.8 million    - The Group's improving cash flow generation capacity is enabling the early cancellation of $50 million of the Group's credit facility by the end of May, with the term facility reducing from $1,125 million to $1,075 million. Upon cancellation, the Group's cash and available bank facilities will therefore reduce by $50 million * The Group has hedged c.7.5 MMbbls of oil for 2018 at an average price of c.$62/bbl EnQuest Chief Executive, Amjad Bseisu, said: "Production performance has been in line with expectations, underpinning our confidence in delivering a material increase in production in 2018. At the same time, we are on track to deliver on our cost and capital expenditure targets. The improving cash flow generating capacity of the Group is enabling early cancellation of $50 million of bank debt and we remain on plan for a further reduction in debt during the year. "Our programme of improving the performance of mature hydrocarbon assets continues to deliver notable successes, with additional production following the drilling of two new wells at Heather and Magnus. Drilling operations on the second well at Magnus have commenced, whilst EnQuest's first ever drilling programme at PM8/Seligi is also now underway. These activities, combined with the DC4 drilling programme at Kraken which is scheduled to commence in the fourth quarter, underpin the Group's targeted delivery of production and cash flow growth." Production details Production on a Net daily average1 Net daily average1working interest Jan' 2018 to 30 Apr' Jan' 2017 to 30 Apr'basis 2018 2017 (Boepd) (Boepd)Northern North Sea 19,851 17,274Central North Sea 6,044 11,572Kraken 21,431 1 -Total UKCS 47,326 28,846Total Malaysia 8,751 9,010Total EnQuest 56,077 37,856 1 Average gross production excluding the maintenance shutdown period in March has been over 36,000 Bopd in the period.  Northern North Sea operations Average production in the four months to end April 2018 of 19,851 Boepd was 14.9% higher than the same period in 2017. This increase was driven by the contribution from Magnus and better than expected initial production at Heather from the near-field H-67 well which was completed and brought online in March, partially offset by natural declines across the Northern North Sea area. At Magnus, production performance has been strong and the planned maintenance shutdown was successfully completed ahead of schedule. In May, first production from the recently drilled M-62 well was delivered, with drilling operations subsequently commencing on the second well (M-63). Higher plant uptime and reliability at Thistle combined with the re-instatement of the Dons South West water injection line are part of an improvement in production and water injection efficiency across the area.  As planned, EnQuest continues to pursue a series of partner-funded idle well reservoir abandonments as part of the Group's asset life extension strategy, improving asset integrity and reducing longer-term decommissioning costs. At Thistle, the first two well abandonments have been successfully concluded ahead of schedule and at a significantly lower cost than anticipated. EnQuest has continued to deliver safe and stable operations at the Sullom Voe Terminal. The Group is making progress in optimising its planned work programme as well as identifying and implementing cost-efficiency initiatives. Central North Sea operations Average production in the four months to end April 2018 of 6,044 Boepd was 47.8% lower than the same period in 2017, driven by similarly significant reductions at both Scolty/Crathes and Alma/Galia as expected. At Scolty/Crathes, wax in the flowline continues to limit production and is being managed with chemical and lift gas treatments while a permanent solution continues to be developed with our partners. At Alma/Galia, production will continue to be low until the three-well Electric Submersible Pump related workovers are completed around the end of Q3. Production efficiency for the Greater Kittiwake Area has improved reflecting the successful completion of production optimisation workscopes in 2017, while output from Alba has been in line with expectations. Kraken The FPSO has performed well during three major storms, although extreme cold weather in early March resulted in Kraken being shut down. During this period, the Group undertook much of the previously planned April shutdown maintenance workscope, meaning the planned shutdown was no longer required. The subsurface continues to deliver in line with expectations. Modelling shows a clear indication of pressure support from injector wells to producer wells, while chemical tracers have confirmed uniform production across the entire length of the wells and no tracers from the injected water have been observed. Average gross production in the four months to end April, which includes the impact of the March maintenance shutdown, was in line with expectations. Excluding the impact of the shutdown, gross production averaged over 36,000 Bopd. Since first production, almost 7 million barrels of oil have been produced and 13 cargoes offloaded from the FPSO, with 9 of these cargoes offloaded in 2018. Cargo pricing continues to be healthy reflecting the quality of Kraken crude. The subsea infrastructure for DC4 is scheduled to be installed in the third quarter, with the drilling programme expected to commence in the fourth quarter, when the Transocean Leader drilling rig relocates from the Alma/Galia field. First production from DC4 is expected in early 2019. Malaysian operations Average production in Malaysia in the four months to end April 2018 of 8,751 Boepd was 2.9% lower than 2017, primarily reflecting natural decline at Tanjong Baram. Production efficiency remained high at PM8/Seligi, with the Group's planned idle well intervention programme commencing in March. The drilling rig arrived in the Seligi field in early May and has now commenced operations on the first of the Group's 2018 two-well programme. First production from this programme is expected in the third quarter. 2018 outlook reaffirmed The Group expects material net production growth in 2018 to within the guidance range of c.50,000 to 58,000 Boepd. Planned maintenance shutdowns at a number of the Group's fields are predominantly scheduled over the summer. The drilling programmes at Magnus and PM8/Seligi, along with the workover programme at Alma/Galia, are expected to deliver production improvements later in the year, with the DC4 programme at Kraken expected to come into production in 2019. All other guidance is reaffirmed. Ends For further information please contact: EnQuest PLC                                 Tel: +44 (0)20 7925 4900 Amjad Bseisu (Chief Executive) Jonathan Swinney (Chief Financial Officer) Ian Wood (Communications & Investor Relations)   Tulchan Communications             Tel: +44 (0)20 7353 4200 Martin Robinson      Martin Pengelley Notes to editors ENQUEST EnQuest is one of the largest UK independent producers in the UK North Sea. EnQuest PLC trades on both the London Stock Exchange and the NASDAQ OMX Stockholm. Its operated assets include Thistle/Deveron, Heather/ Broom, the Dons area, Magnus, the Greater Kittiwake Area, Scolty/Crathes Alma/Galia and Kraken; EnQuest also has an interest in the non-operated Alba producing oil field. At the end of December 2017, EnQuest had interests in 25 UK production licences and was the operator of 23 of these licences. EnQuest believes that the UKCS represents a significant hydrocarbon basin, which continues to benefit from an extensive installed infrastructure base and skilled labour. EnQuest believes that its assets offer material organic growth opportunities, driven by exploitation of current infrastructure on the UKCS and the development of low risk near field opportunities. EnQuest is replicating its model in the UKCS by targeting previously underdeveloped assets in a small number of other maturing regions; complementing its operations and utilising its deep skills in the UK North Sea. In which context, EnQuest has interests in Malaysia where its operated assets include the PM8/Seligi Production Sharing Contract and the Tanjong Baram Risk Services Contract. Forward-looking statements: This announcement may contain certain forward-looking statements with respect to EnQuest's expectation and plans, strategy, management's objectives, future performance, production, reserves, costs, revenues and other trend information. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon circumstances that may occur in the future. There are a number of factors which could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements and forecasts. The statements have been made with reference to forecast price changes, economic conditions and the current regulatory environment. Nothing in this announcement should be construed as a profit forecast. Past share performance cannot be relied on as a guide to future performance. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.   END

Ingalill Östman leaves her position as Director of Corporate Communications at Castellum

Since January 2017, Ingalill Östman has been part of the Executive Team with overall responsibility for Castellum's communications. During that time, a more coordinated organization and working method for communication has been established, including a greater focus on digital and social channels. In addition, a focused positioning and branding effort has been implemented to increase visibility and knowledge of Castellum's offerings. ”I want to sincerely thank Ingalill for her solid and wholehearted efforts to develop Castellum's brand and position and wish her the best of luck for the future”, says Henrik Saxborn, Castellum’s CEO.  The process of recruiting a successor as Director of Corporate Communications at Castellum has been initiated. This information is information that Castellum is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out below, at 8:00 am CET on May 24, 2018. For additional information, please contact:Henrik Saxborn, CEO Castellum AB, phone +46 31 60 74 50Ingalill Östman, Director of Corporate Communications Castellum AB, phone +46 703 54 41 27www.castellum.com  Castellum is one of the major listed real estate companies in Sweden. The fair value of the real estate portfolio amounts to approx. SEK 82 billion and comprises commercial properties for office, retail, warehouse and logistics with a total lettable area of approx. 4.4 million sq. m.     The real estate portfolio is owned and managed under the Castellum brand through a decentralized organization with strong and clear local presence in 20 cities from Copenhagen in the south to Sundsvall in the north.    In 2017, Castellum received two awards for sustainability efforts; designated Number One in the world by GRESB for the offices-and-logistics sector, as well as the Level Gold award for sustainability reporting from the EPRA (European Public Real Estate Association). In addition, Castellum is the only Nordic real-estate and construction company elected to the Dow Jones Sustainability Index (DJSI), joining a select group of companies in the world who perform best on sustainability issues.    The Castellum share is listed on Nasdaq Stockholm Large Cap. Castellum AB (publ), Box 2269, SE-403 14 Gothenburg | Corp Id no SE 556475-5550 | Phone +46 31 60 74 00

GomSpace (provider of nanosatellites) announces its quarterly results for the first quarter 2018

Stockholm, May 24, 2018. GomSpace Group AB (the “Company”) announces its interim report for the first quarter of 2018. The report is available on the Company’s homepage (www.gomspace.com). The following is taken from the quarterly report: “We are very happy to welcome the new shareholders who joined GomSpace in the directed share issue at the beginning of March. This new capital puts us in a good position to carry through our accelerated growth plans. We are pleased that we also in this quarter continued to grow considerably faster than our goal at 70% which was in our original plans. Net revenues in the first quarter 2018 were T.SEK 37,738 compared to T.SEK 18,997 in the first quarter of 2017. The growth in revenue exceeds our plans. In the first quarter 2018 the growth was 99% compared to the first quarter of 2017 and it grew 27% compared to the fourth quarter of 2017. Without the partial elimination of revenue from Aerial & Maritime Ltd., the growth in revenue would have been 102% in the first quarter 2018.” CEO Niels Buus commented. First quarter summary 1 January – 31 March 2018 (2017) ·  Net revenues increased to T.SEK 37,738 (18,997) ·  Gross margin decreased to 35% (46%) ·  Operating profit (loss) decreased to a negative T.SEK 15,093 (a negative 10,257) ·  Earnings per share were a negative SEK 0.52 (a negative 0.42) ·  Order book amounts to T.SEK 723,433 as at 31 March 2018. We expect to convert SEK 110-140 million of the current backlog into revenue during 2018 ·  GomSpace raises SEK 125 million through a directed new issue of shares and evaluates the possibility to move the listing of its shares to Nasdaq’s main market Subsequent events ·  Successful commissioning of GOMX-4 nanosatellites For more information, please contact:Niels Buus (CEO)Tel: +45 40 31 55 57Email: nbu@gomspace.com About Gomspace Group AB The Company’s business operations are mainly conducted through the wholly-owned Danish subsidiary, GomSpace A/S, with operational office in Aalborg, Denmark. GomSpace is a space company with a mission to be engaged in the global market for space systems and services by introducing new products, i.e. components, platforms and systems based on innovation within professional nanosatellites. The Company is listed on the Nasdaq First North Premier exchange under the ticker GOMX. FNCA Sweden AB is the Company’s Certified Adviser. For more information, please visit our website on www.gomspace.com. Miscellaneous       +------------------------------------------------------------------------------+|This information is information that GomSpace is obliged to make public ||pursuant to the EU Market Abuse Regulation. The information was submitted for ||publication, through the agency of the contact person set out above, 8:00 a.m.||CET on May 24, 2018. |+------------------------------------------------------------------------------+

NEW PRODUCT LAUNCH AND CONTINUED GROWTH IN Q1

IMPORTANT EVENTS  DURING THE PERIOD · In March, industry veteran Matt Nitzberg joined Nepa USA in the role of Chief Client Officer, and thereby substantially strengthening the US sales organization. Matt was instrumental in growing sales of dunnhumby USA.  · Launched the application CX Tracker within our Customer Experience offering that targets mid-sized companies and companies that are in the early stages of their journey to improve customer experience. The CX Tracker provides an entry point to our Customer Experience offering, expanding our addressable market and creating future upselling opportunities.   · Development of the Path-to-Purchase application that helps global Consumer Packaged Goods companies understand the importance of every online and offline touchpoint in their consumers’ decision journeys. AFTER THE PERIOD ENDED · Completes the last adaptations in our systems and processes, including the migration to a new main data gathering tool to be fully compliant to the GDPR, the EU’s new personal data regulation. A WORD FROM OUR CEO  Nepa has taken several steps towards reaching our goals in the first quarter of 2018, by developing our products and services and intensifying our expansion in the UK and the USA. We help our clients meet the challenge of transforming enormous amounts of data to actionable insights by developing solutions that distribute the right data, to the right decision maker, at the right time. Some of the things we have done include: · Launched CX Tracker, a new application in our Customer Experience offering that targets mid-sized companies and companies that are in the early stages of their journey to improve customer experience. The CX Tracker provides an entry point to our Customer Experience offering – expanding our addressable market and creating future upselling opportunities. · Development of our Path-to-Purchase application - helping global Consumer Packaged Goods companies understand the importance of every online and offline touchpoint in their consumers’ decision journeys. Path-to-Purchase enables our clients to optimize investment at every step of the consumers’ buying process. The product has had a breakthrough on the UK market and we have been invited by ESOMAR to present our findings at their annual Shopper Experience event in Amsterdam in June this year. · GDPR compliance - During the first quarter we have invested in making the last adaptations in our systems and processes to be fully compliant to the GDPR, the EU’s new personal data regulation. Among others we have completed the migration to a new main data gathering tool, a process we have invested close to 8,000 hours into over the last six months. We are ready for GDPR and the opportunities it presents when it comes into force tomorrow on May 25th and we are convinced that it will be a competitive advantage for Nepa. · We have continued to increase the scalability of our  ActionHub® platform and also changed the name to Consumer Science platform®. Nepa defines Consumer Science as the inter­section between Consumer Research and Data Science. The nomination committee for Nepa has suggested Jan Carlzon and Annika Steiber as new board members for Nepa, subject to election at the annual general meeting on May 31st. Jan Carlzon, former CEO of SAS, has a global network and extensive experience within consumer-oriented and decentralized management. Annika Steiber PhD brings a solid academic background, an extensive network in the USA, and innovation expertise. Annika is based in Silicon Valley and the author of several books (incl. “The Google Model - Management for Continuous Innovation in a Rapidly Changing World”). We are hoping to welcome both to the board. I also want to give my warm thanks to Anne Roggeveen, who is not available for re-election. Anne has given great contributions to Nepa, both in the board meetings and in supporting our operations in the USA. Nepa continued to grow in Q1 for the 48th consecutive quarter. Net sales grew by 12.7 percent to MSEK 57.6 and gross profit grew by 11.6 percent to MSEK 42.7. EBIT amounted to MSEK -5.1 MSEK. At the same time, growth in personnel costs continued to slow down for the fourth consecutive quarter – from a growth rate of 40 percent in Q1 2017 to 9 percent in Q1 2018. With stronger net margins in our Swedish market, an improved product portfolio, and international business growth –  we are optimistic about our success in 2018 and beyond. Fredrik ÖstgrenCEO Erik Penser Bank is Nepa’s Certified Adviser.

Changes to Coor’s management

Johan Mild is resigning as President of Coor Finland to take up a new position outside Coor. Coor’s SVP of Operations Development, Rikard Wannerholt, will temporarily take over the position until a replacement is found. The recruitment process for a replacement for Johan Mild has been initiated. Johan Mild will stay with Coor until 31 August.The information is disclosed pursuant to the Swedish Financial Instruments Trading Act. The information was submitted for publication on May 24, 2018, at 08.05 CET.For more information, images etc. please visit www.coor.com or contact: Mikael Stöhr, President and CEO, Coor +46 10 559 59 35mikael.stohr@coor.com Magdalena Öhrn, Communications Director, Coor+46 10 559 55 19magdalena.ohrn@coor.com Coor is a leading provider of facility management services in the Nordics, focusing on integrated and complex service undertakings (IFM). Coor offers specialist expertise in workplace services (soft FM), property services (hard FM) and strategic advisory services for development of customers’ service activities. Coor creates value by executing, leading, developing and streamlining its customers’ service activities, ensuring that they provide optimal support to the core business over time. Coor’s customer base includes many large and small companies and public-sector organisations across the Nordic region, including ABB, AB Volvo, Aibel, Det Norske Veritas, E.ON, Ericsson, EY, NCC, Politiet (Danish Police), Saab, Sandvik, SAS, Statoil, Telia Company, Swedish Transport Administration, Vasakronan and Volvo Cars. Coor was founded in 1998 and is listed on Nasdaq Stockholm since 2015. Coor takes responsibility for the operations it conducts, in relation to its customers, employees and shareholders, as well as for its wider impact on society and the environment. Read more at www.coor.com

Catena Media makes strategic push into global forex with addition of ForexTraders.com

Catena Media plc is paving the way for its global ambition to become a leader in quality content generation, and subsequent lead generation, in financial services. The acquisition of Forextraders.com , Forexcharts.net  and Forexindicators.net , alongside additional sites, lays the foundation for the global ambition within foreign exchange trading content and lead generation. All of the sites will be used to create an ecosystem of quality content in the area of Foreign exchange as part of the Trade Finance vertical. This provides the opportunity to improve sites currently focusing on advertising so that they instead focus on lead generation. The acquired assets currently generate quarterly sales of about USD 250,000. “Foreign exchange represents major trading volumes, both for professional and non-professional traders requiring reliable information - Catena Media has set-out to become the leader in this space.” Henrik Persson Ekdahl, Acting CEO  ForexTraders.com  started in 2004. It is a foreign exchange trading Information site providing details of foreign exchange brokers, sign-up offers and useful information pertaining to the area of foreign exchange. Catena Media will extend this by adding premium content relating to various currencies, newsletters and instructional videos and newscasts.  The initial purchase price of ForexTraders.com, payable in conjunction with the transfer of the assets, amounts to an up-front cash payment of USD 4.08 million. In addition, there is an earn-out of a maximum USD 1.58 million based on revenue performance over a period of 12 months, and 50 percent of the earn-out may be paid in shares. The expected total acquisition cost is USD 5.26 million, with the earn-out likely amounting to USD 1.18 million. In a reasonable anticipated scenario, with a total earn-out of USD 1.18 million, the sellers would need to generate revenue growth of between 30 and 40 percent over the period. For further information, please contact:   Henrik Persson Ekdahl, Acting CEO, Catena Media plcPhone: +46 706 91 43 43, E-mail: henrik.persson@catenamedia.com Åsa Hillsten, Head of IR & Communications, Catena Media plc Phone: +46 700 81 81 17, E-mail: asa.hillsten@catenamedia.com The information was submitted for publication, through the agency of the contact persons set out above, on 24 May 2018 at 08:45 CET About Catena Media Catena Media provides companies with high-quality online lead generation. Through strong organic growth and strategic acquisitions, Catena Media has, since 2012, established a leading market position with approximately 300 employees in the US, Australia, Japan, Serbia, UK, Sweden and Malta (HQ). Total sales in 2017 reached EUR 67.6 million. The company is listed on Nasdaq Stockholm Mid Cap. Further information is available at www.catenamedia.com 

STRAX: INTERIM REPORT NO 1 FOR THE FINANCIAL YEAR 2018

· The Group’s sales for the period January 1 – March 31, 2018, amounted to MEUR 22 (20), gross margin increased to 30.4 (27.0) percent. · The Group’s result for the period January 1 – March 31, 2018, amounted to MEUR 0 (0) corresponding to EUR 0.00 (0.00) per share. Equity as at March 31, 2018 amounted to MEUR 21.0 (18.2) corresponding to EUR 0.17 (0.15) per share. · EBITDA for the period January 1 – March 31, 2018, amounted to MEUR 1.0 (0.6) an increase of 67% to be compared with a sales growth of 9% for the same period. The scalable growth model shows greater increase in profitability in relation to growth of revenues. · STRAX was awarded accessory contract with Vodafone UK to become its sole provider of mobile accessories across all of its 450 retail stores, enterprise business units and online channels via a full category vendor managed availability solution. · STRAX implemented a supply chain financing solution from CrossFlow, a London-based fintech company, within its supplier base. ”The House of Brands positioning coupled with our distribution capabilities in Western Europe has proved very successful with our customers.”                                                                                                                                                                Gudmundur Palmason, CEO  This information is information that Strax AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 08:55 CET on May 24, 2018.

Basware announces move to functional organizational structure to support cloud growth

Basware Corporation, stock exchange release, May 24, 2018 at 10:00amBasware announces move to functional organizational structure to support cloud growth Basware today announces that it will move to a functional organizational structure and establish three new functions: Products, R&D and Production, and Business Development and Alliances. The current Business Area organizations will be integrated into the new functions. The new organization will be valid as of June 1, 2018. “Our vision is to deliver the best global solution for purchasing, invoicing and paying. With our new organization I am confident we can lift our partner ecosystem to a new level and innovate even faster. Our customers benefit greatly from using our services. With the actions we are now taking, we believe we can reach out to even more new customers and serve existing customers even better. In addition, the new organization will further support our strategic targets of strong cloud revenue growth and scalability of operations”, says Vesa Tykkyläinen, CEO, Basware Corporation. Ilari Nurmi, currently head of Basware’s Purchase-to-Pay business area, will lead the newly established Business Development and Alliances function. Mikko Pilkama, currently the head of Basware’s Network and Financing Services, will lead the new Products function. Nurmi and Pilkama continue as members of the company’s Executive Team in their new roles. Other members of the Executive Team continue in their current roles. As part of the change, Basware announces the creation of a new Chief Technology Officer (CTO) position, which will head the R&D and Production function. The CTO will report to Vesa Tykkyläinen, CEO, Basware Corporation. Jari Antikainen, currently Vice President, Purchase-to-Pay, R&D at Basware, acts as the company’s interim CTO until the appointment is finalized. With the changes Basware will achieve estimated annual run-rate savings of EUR 2-3 million, which will be reinvested into growth areas. The costs related to implementing the changes are expected at EUR 1-2 million. For more information, please contact:Investor enquiries: Ben Selby, Head of Investor Relations, Basware CorporationTel. +358 50 305 8077, ben.selby@basware.com Media enquiries: Jukka Jänönen, Communications Director, Basware CorporationTel. +358 400 127 147, jukka.jänönen@basware.com (jukka.j%C3%A4n%C3%B6nen@basware.com) Distribution:Nasdaq HelsinkiKey mediainvestors.basware.com/en About Basware:Basware  (Nasdaq: BAS1V) is the global leader in providing networked source-to-pay solutions, e-invoicing and value added services. Basware’s commerce and financing network connects businesses in over 100 countries and territories around the globe. As the largest open business network in the world, Basware provides scale and reach for organizations of all sizes, enabling them to grow their business and unlock value across their operations by simplifying and streamlining financial processes. Small and large companies around the world achieve significant cost savings, more flexible payment terms, greater efficiencies and closer relationships with their suppliers. Find out more at https://investors.basware.com/en. Follow Basware on Twitter: @Basware , join the discussion on the Basware LinkedIn , Basware Facebook  and Basware Blog .

YIT and Hollister Incorporated signed an agreement to construct the second stage of a healthcare product factory in Lithuania

YIT has signed a contract with Hollister Incorporated, a US-based medical products manufacturing company, to construct the second stage of a medical device factory in Kaunas, Lithuania. The value of the deal for YIT is approximately EUR 25 million and the project will be recorded in the order backlog in the second quarter. The construction of the second stage will begin in spring 2018 and it will be completed in spring 2019. The factory will cover 24,000 square metres of land. YIT has signed a contract also for the first stage in 2017. For further information, please contact: Hanna Jaakkola, Vice President, Investor Relations, YIT Corporation, tel. +358 40 5666 070, hanna.jaakkola@yit.fi Peter Forssell, Vice President, Head of Business Premises, Central Eastern Europe, YIT Construction Ltd, tel. +358 204 33 111, peter.forssell@yit.fi YIT CORPORATION Hanna Jaakkola Vice President, Investor Relations Distribution: Nasdaq Helsinki, major media, www.yitgroup.com  YIT is the largest Finnish and significant North European construction company. We develop and build apartments, business premises and entire areas. We are also specialised in demanding infrastructure construction and paving.  Together with our customers our 10,000 professionals are creating more functional, more attractive and more sustainable cities and environments. We work in 11 countries: Finland, Russia, Scandinavia, the Baltic States, the Czech Republic, Slovakia and Poland. The new YIT was born when over 100-year-old YIT Corporation and Lemminkäinen Corporation merged on February 1, 2018. Our pro forma revenue for 2017 was over EUR 3.8 billion. YIT Corporation's share is listed on Nasdaq Helsinki Oy. www.yitgroup.com 

Rejlers sells Norwegian telecom business to OneCo

“The telecom operation in Norway is based on a different business model than that of Rejlers’ core business and is not similar to our other telecom operations. Our core business is leading IT and technology consultancy services in Sweden, Norway and Finland, and this is where we will target our resources going forward,” says Viktor Svensson, President and CEO of Rejlers. Agreement concerning the sale of Rejlers Telecom ASRejlers Norge AS has today signed an agreement with OneCo AS concerning the sale of Rejlers Telecom AS. The proceeds from the sale amount to NOK 12,3 million including sale costs and will generate a preliminary sales profit of around NOK 4 million. The company will be excluded from Rejlers’ financial statements with effect from 1 June 2018. Rejlers Telecom AS has 90 employees and an annual turnover of approximately NOK 120 million. The transaction is subject to the Norwegian Competition Authority approval. A good fit with OneCo’s business “Rejlers’ telecom business has more potential for development within One Co. Rejlers Telecom AS has a different business model and few synergies with our other business areas in Rejlers Norway. We therefore believe that Rejlers Telecom will be an excellent match for the OneCo Group, which has telecom as part of its core business. It will benefit all employees and customers, as the new owners will be able to add substantial market synergies which will contribute to further development,” says Thomas Pettersen, CEO Rejlers Norway.     About OneCoOneCo is a well-established company in Norway with 800 employees and a turnover of NOK 1.5 billion. The operation in the Norwegian market primarily focusses on social infrastructure such as electrical power and telecommunication networks. OneCo is also represented in Sweden through OneCo Sverige AB, which aims to take up a similar position in the Swedish market. About Rejlers NorwayRejlers Norway provides services to customers across the Nordic region and is represented in all the major cities of Norway, as well as in Motala and Gothenburg in Sweden. Following the sale of Rejlers Telecom AS, we will have around 250 employees and an expected annual turnover of approximately NOK 430 million. We possess unique know-how concerning digitalisation combined with business consultancy expertise within the sectors in which we operate. We generate commercial benefits for our customers through the digitalisation of physical infrastructure, smart choices and strategic use of IT within customer areas such as energy, retail, infrastructure and buildings. We are part of the Rejlers Group, which has 75 years of experience operating as an advisor and technology consultant for industry and the public sector across the Nordic region. Rejlers is listed on Nasdaq Stockholm. www.rejlers.no For further information:Viktor Svensson; President and CEO, tel. +46 (0)70 657 20 26, e-mail: viktor.svensson@rejlers.seThomas Pettersen; CEO Rejlers Norway, tel. +47 950 22 323, e-mail: thomas.pettersen@rejlers.noRejlers is one of the largest engineering consultancy firms in the Nordic region. Our 2,000 experts work with projects in the areas of  Energy, Buildings, Industry, Infrastructure and Telecom. At Rejlers, you will meet specialist engineers with the knowledge, cutting edge expertise and energy to achieve results. We can be found in 75 locations in Sweden, Finland and Norway. Rejlers recorded revenue of SEK 2.5 billion in 2017 and its class B share is listed on Nasdaq Stockholm.This information is such that Rejlers AB (publ) is obliged by the EU market abuse directive to publish. The information was submitted through the care of the contact person above for publication on 24 May 2018 at 09:30 CET. 

Tobias Lindquist appointed CFO for Alimak Group

Tobias Lindquist currently holds the position of Chief Financial Officer English First at EF and has been based in China for the last ten years. Prior to that he has held various positions within EF as well as 3IC Inc and Ericsson. He holds BA degrees from Stockholm University and Middlesex University. “We are very pleased to welcome Tobias Lindquist to Alimak Group. He is a strong and good addition to the Group and we look forward to work with him on developing the CFO function further”, says Tormod Gunleiksrud, CEO Alimak Group. Interim CFO Stefan Rinaldo will continue in his position as Chief Operational Officer. “I am happy to join Alimak Group and feel strongly about the company’s commitment to enhancing customer safety, productivity and profitability. I am looking forward to contributing with my experiences to the company’s interesting journey ahead”, says Tobias Lindquist. For further information, contact: Tormod Gunleiksrud, CEO, +46 8 402 14 40 Mathilda Eriksson, IR Manager, +46 8 402 14 41 This information is information that Alimak Group AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 11:55 CEST on 24 May 2018. About Alimak GroupAlimak Group is a world-leading provider of vertical access solutions for the industry and construction sectors. With a presence in more than 100 countries, Alimak develops, manufactures, sells and provides service to vertical access solutions with focus on adding customer value through greater safety, higher productivity and improved cost efficiency. The Group’s products and solutions are sold under the brands Alimak Hek, CoxGomyl, Manntech and Avanti. Alimak has an installed base of more than 67,000 elevators, hoists, platforms, service lifts and building maintenance units around the world. Founded in Sweden 1948, Alimak has its headquarters in Stockholm, 12 manufacturing facilities in 8 countries and 2,400 employees around the world. www.alimakgroup.com

Targovax strengthens 2-year survival rate in resected pancreatic cancer with TG01

Oslo, Norway, 24 May 2018 - Targovax ASA (“Targovax” or “the Company”; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces the completion of the 32-patient phase I/II clinical trial evaluating TG01 in resected pancreatic cancer in combination with standard of care chemotherapy (gemcitabine). Median overall survival (mOS) for all 32 patients was 33.4 months, which is nearly six months better than the mOS of 27.6 months for gemcitabine alone reported in the recent ESPAC4 trial(1). The trial enrolled a total of 32 patients, split in two patient cohorts receiving different dosing regimens. The first cohort consists of 19 patients, receiving TG01 injections, before, during and after adjuvant chemotherapy treatment. In February 2017, two-year survival rate of 68% (13/19 patients) and mOS of 33.1 months was reported for this cohort. The second cohort consists of 13 patients on a reduced dosing regimen, with TG01 injections before and after, but not during, chemotherapy treatment. Two-year survival rate in the second cohort was 77% (10/13 patients), higher than the 68% two-year survival rate reported for the first cohort in 2017, as well as published historical rate of 30-53% for gemcitabine. Median OS in the second cohort has not yet been reached. The dosing regimen used in the second cohort was well tolerated and will be used for continued development. When combining the results from the two cohorts, mOS for all 32 patients was 33.4 months, strengthening the previously reported signal of clinical efficacy of TG01 treatment in combination with chemotherapy. Targovax will seek to continue to monitor the treated patients in order to assess long-term survival. Summarizing the top-line data for the 32 patients in this phase I/II trial, the following was observed: ·  Median overall survival (mOS) was 33.4 months ·  94% of patients (30/32) were alive one year after surgery ·  72% of patients (23/32) were alive two years after surgery ·  90% of patients (29/32) demonstrated mutant RAS-specific immune activation The full data set, including immune monitoring, will be further analyzed and presented at a relevant scientific conference. Professor Daniel H. Palmer, University of Liverpool Cancer Research UK Experimental Cancer Medicine Centre, Liverpool, United Kingdom and lead investigator of the study, commented:   “Pancreatic cancer is a highly malignant, difficult to treat disease and there is a significant need for innovative new treatment approaches. The results from this study are promising and demonstrate that TG01 is generally well tolerated in combination with gemcitabine. We observe a high level of mutant RAS-specific immune activation, and the observed survival rate is encouraging compared with chemotherapy alone. It will now be important to assess the clinical efficacy of the TG01 and standard of care combination treatment in a randomized setting, and we look forward to take part in the development of this innovative immunotherapy going forward”. Øystein Soug, Chief Executive Officer of Targovax commented: “These more mature survival data represent another important milestone for Targovax. The high rate of immune activation, combined with the encouraging survival data which compares well with the large ESPAC4 trial, further strengthens our belief that our mutant RAS neoantigen vaccine has potential to be a promising new treatment approach in combating mutant RAS tumors, which constitutes up to 30% of all cancers.”  (1) Neoptolemos JP et al.; The Lancet; 389:1011-1024 (2017)  About the study CTTG01-01 is an open label phase I/II trial of TG01/GM-CSF in combination with gemcitabine as adjuvant therapy for treating patients with resected adenocarcinoma of the pancreas. The main objectives of the trail are an assessment of safety and immune activation. The secondary objective is to assess efficacy (disease-free survival and overall survival) at two years. The Company has received consent to enable the reporting of overall survival for all patients in the trial. The trial has been conducted in four centres in the UK and Norway.   The first cohort of 19 patients each received up to 36 injections of TG01/GM-CSF, before, during and after six cycles of gemcitabine. The second cohort consists of 13 patients, who received up to 15 injections of TG01/GM-CSF before and after, but not during, gemcitabine treatment. Overall, the treatment is well tolerated in both dosing regimens. Although manageable, some allergic reactions were seen in patients in the first cohort when treating with TG01 and gemcitabine in parallel. No such allergic reactions were seen in the second cohort.  TG01 is Targovax’s lead product candidate from its mutRAS neoantigen cancer vaccine program. The product is an injectable peptide-based immunotherapy designed to treat patients with mutant RAS solid tumors. RAS mutations are the most frequently found oncogenic mutations in cancer overall, and are associated with poor prognosis. Published data suggests that more than 90% of pancreatic cancer patients have mutant RAS. For further information, please contact:Renate Birkeli, Investor RelationsPhone: +47 922 61 624Email: renate.birkeli@targovax.com   Media and IR enquires:Andreas Tinglum - Corporate Communications (Norway)Phone: +47 9300 1773Email: andreas.tinglum@corpcom.noSimon Conway/Stephanie Cuthbert - FTI Consulting (International)Phone: +44 20 3727 1000Email: Targovax@fticonsulting.com About Targovax Arming the patient's immune system to fight cancer Targovax (OSE:TRVX) is a clinical stage company focused on developing and commercializing novel immuno-oncology therapies to target, primarily, treatment-resistant solid tumors. Immuno-oncology is currently one of the fastest growing therapeutic fields in medicine. The Company’s development pipeline is based on two novel proprietary platforms: The first platform, ONCOS, uses oncolytic viruses as potential multi-target, neo-antigen therapeutic cancer vaccines. ONCOS uses an adenovirus that has been engineered to be an immune activator that selectively targets cancer cells. In phase I trials it has demonstrated immune activation at lesional level which was associated with clinical benefit. In an ongoing phase I trial in advanced melanoma we expect important proof of concept data for checkpoint inhibitor refractory patients. The second platform, TG, are neo-antigen cancer vaccines designed to specifically treat tumors that express mutated forms of RAS. Mutations to the RAS protein are common in many cancers and are known to drive aggressive disease progression and treatment resistance. There is a high unmet medical need for therapies that are effective against tumors that express these mutations. The TG platform’s therapeutic potential stems from its ability to enable the patient’s immune system to identify and destroy tumors bearing any RAS mutations. In early 2017, key proof of concept data for the TG platform from a clinical trial of TG01 in resected pancreatic cancer patients showed encouraging overall survival and will give guidance for the future clinical development of this platform. Targovax’s development pipeline has three novel therapeutic candidates in clinical development covering six indications. Both platforms are protected by an extensive portfolio of IP and know-how and have the potential to yield multiple product candidates in a cost-effective manner. Additionally, Targovax has other products in early stages of development. 

PAXMAN publishes its interim report for the period 1 January to 31 March 2018

The Group’s sales amounted to 11.0 MSEK in the first quarter of the year, with a net loss totalling -1.7 MSEK. Earnings per share were -0.10 SEK for the period. Cash flow before financing activities was -6.8 MSEK. Total assets amounted to 43.7 MSEK at 31 March, and net liquid assets to -1.2 MSEK. Equity to assets ratio was 71.7 % at the end of the reporting period. The 10 MSEK credit line secured earlier this year is yet to be utilized. In the first quarter of the year, PAXMAN signed a license agreement for Mexico with Teva Pharmaceutical Industries, which means that PAXMAN’s Scalp Cooler will be established on a brand new market with over 150,000 new cancer cases per year. On 22 January, PAXMAN announced that the company had received a 10 MSEK credit line to be used as a financial buffer to increase the rate of expansion on the US market. In February, PAXMAN announced a new agreement with The University of Texas MD Anderson Cancer Center to install 16 scalp cooling systems in three of its Houston locations. Twelve of the systems will be installed at one single clinic, making it the largest single PAXMAN installation yet. By late February PAXMAN had signed delivery agreements with all the five highest-ranked cancer centers in the US, and in early March PAXMAN reached its initial milestone of installing or signing delivery agreements for 250 scalp cooling systems in the USA within one year after its FDA clearance in April 2017. After the reporting period PAXMAN has applied for SHONIN approval in Japan, the application based on a clinical trial with five leading cancer clinics in the country. On 19 April PAXMAN received market approval in Mexico, which means that Teva and PAXMAN may now intensify their work with an official launch on the Mexican market. In late April PAXMAN announced an update of its accounting treatment of the acquisition of Paxman Group Ltd, which improved the group’s net result for the year 2017 by 1.1 MSEK. In early May, PAXMAN supplemented its premarket notification application to the US FDA for an expanded indication by responding to a request for additional information and analyses. 

Meet Senzime during June

Senzime to Participate in Jefferies 2018 Healthcare Conference in New York Press Release: Uppsala, May 24, 2018, Senzime AB (SEZI), developer of unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery, today announced that its CEO, Lena Söderström, will be attending at the Jefferies Global Healthcare Conference at the Grand Hyatt New York, June 5-8, 2018. Lena Söderström, Senzime’s CEO, will be representing the company and hosting one-on-one meetings during the conference. To schedule a meeting with Mrs. Söderström, please contact lena.soderstrom@senzime.com.   Senzime to present at Småbolagsdagen, held in Stockholm, June 11 Senzime will present at Småbolagsdagen, a small-cap investor conference, held in Stockholm on June 11 (Sheraton Stockholm Hotel). The event is arranged by Aktiespararna and the company will be represented by CEO Lena Söderström. This event is webcasted on www.smabolagsdagen.net. The presentation will be available on the company’s website after the presentation. For full program and registration, see link.   For further information, please contact:  Lena Söderström, CEO of Senzime AB Tel: +46 708-16 39 12, email: lena.soderstrom@senzime.com  TO THE EDITORS   About Senzime   Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The portfolio of technologies includes bedside systems that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patients’ neuromuscular function perioperatively and in the intensive care medicine setting. The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. Senzime operates in growing markets that in Europe and the United States are valued in excess of SEK 10 billion. The company's shares are listed on Nasdaq First North (ticker SEZI). FNCA is Certified Adviser for Senzime. www.senzime.com 

Autoliv Board approves completion of spin-off

(Stockholm, Sweden, May 24, 2018) – Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, today announced that its board of directors has approved the completion of the previously announced spin-off of Autoliv’s subsidiary Veoneer, Inc., its electronics segment, into an independent publicly traded company. The company further announced additional members expected to serve on the Veoneer board of directors following completion of the spin-off. Separately Autoliv today announced an agreement with Cevian Capital relating to its ownership in Autoliv and Veoneer. The Autoliv board set the distribution ratio and record and distribution date for spin-off of Veoneer, Inc. The spin-off is on track to be completed on June 29, 2018, with trading in Veoneer to begin on July 2, 2018. The distribution date for Veoneer stock will be June 29, 2018, and Veoneer will begin “regular way” trading on the New York Stock Exchange under the symbol “VNE” and on Nasdaq Stockholm under the symbol “VNE SDB” on July 2, 2018. Autoliv will continue to trade on the New York Stock Exchange under the ticker “ALV” and on Nasdaq Stockholm under the symbol “ALIV SDB”. The Autoliv board today further announced that Mary Cummings, Mark Durcan and Jonas Synnergren are expected to join Veoneer’s board following completion of the spin-off. Dr. Cummings is a professor at the Duke University Pratt School of Engineering, the Duke Institute of Brain Sciences, and is the director of the Humans and Autonomy Laboratory and Duke Robotic. Mr. Durcan is the former Chief Executive Officer of Micron Technology. Mr. Synnergren is a partner at Cevian Capital and head of Cevian’s Swedish office. “The board approval of the spin-off and decision of the timing for the start of trading for Veoneer are key milestones in the project and we look forward to launching Veoneer as a trusted expert partner to the mobility industry and see a focused Autoliv thrive as the worldwide leader in passive safety. I would further like to welcome the new members to the Veoneer board of directors. They each bring unique competencies that will support Veoneer’s value creation in the years to come,” said Jan Carlson, Chairman, President and CEO of Autoliv. Additional Details on the Distribution The Autoliv board has approved a pro rata distribution of all the stock of Veoneer to Autoliv stockholders in a 1 to 1 ratio. In the distribution, Autoliv stockholders (including holders of shares represented by Swedish Depository Receipts (SDRs)) will receive one share of Veoneer common stock for each share of Autoliv common stock held as of their respective record dates outlined below. Veoneer will not issue fractional shares of its common stock in the distribution. No action is required by Autoliv’s stockholders or SDR holders in order to receive shares or SDRs of Veoneer common stock in the distribution. · The record date for the distribution for common stockholders (i.e. those holding shares traded on the NYSE) is the close of business in the U.S. on June 12, 2018. · The record date for the distribution to holders of Autoliv SDRs (i.e. those holding SDRs traded on Nasdaq Stockholm) is July 2, 2018. The Autoliv SDRs will trade excluding the right to receive distribution of Veoneer SDRs as from June 29, 2018. · Beginning on or about June 11, 2018, and continuing up to and through the distribution date (June 29, 2018), it is expected that there will be two ways of trading in Autoliv common stock on the New York Stock Exchange: · “Regular way trading” - shares that trade in the “regular way” market will be entitled to shares of Veoneer common stock distributed pursuant to the distribution. · “Ex-distribution trading” - shares that trade in the “ex-distribution” market will trade without an entitlement to shares of Veoneer common stock distributed pursuant to the distribution. Shares of Autoliv in the “ex-distribution” market will trade under the symbol ALV.wi. If you sell shares of Autoliv common stock in the “regular way” market, you will also be selling the right to receive the shares of Veoneer common stock in the distribution. However, if you sell shares of Autoliv common stock in the “ex-distribution” market, you will still receive the shares of Veoneer common stock in the distribution. · “Regular way” trading in Veoneer’s common stock on the NYSE is expected to begin on July 2, 2018, the first trading day following the distribution date, at which time “regular way” trading in Autoliv’s common stock will reflect the distribution of the Veoneer shares. · Trading in Veoneer SDRs on Nasdaq Stockholm is expected to begin on July 2, 2018. Autoliv SDRs will continue to trade normally on Nasdaq Stockholm up to June 29, 2018, as of which the Autoliv SDRs will trade excluding the right to receive distribution of Veoneer SDRs. · Autoliv anticipates that “when-issued” trading in shares of Veoneer will begin on or about June 11, 2018, and will continue up to and through the distribution date (June 29, 2018). Shares of Veoneer in the “when-issued” market will trade under the symbol VNE.wi. There will not be "when issued" trading in Veoneer SDRs on Nasdaq Stockholm. · Additional information regarding the trading in shares of Autoliv and Veoneer during this period will be available on Autoliv’s website (www.autoliv.com). Changes to Autoliv Audit Committee As previously announced, Robert W. Alspaugh and Wolfgang Ziebart, current members of the Autoliv board and members of the audit committee of Autoliv, will resign from the Autoliv board to serve on the Veoneer board following completion of the spin-off. The Autoliv board announced today that Ted Senko will serve as chairman of the audit committee upon the resignation of Mr. Alspaugh, and that Hasse Johansson will join the audit committee upon the resignation of Mr. Ziebart. Financing In connection with the spin-off and to support its intended cash injection into Veoneer, Autoliv has entered into a US$800,000,000 bridge facility agreement with J.P. Morgan Securities PLC and SEB. The facility has a six-month maturity, which, subject to the banks’ approval, can be extended for an additional six months. The coordinators and bookrunners are J.P. Morgan Securities PLC and SEB and the facility agent is SEB. Also today, in order to facilitate the consent with regard to the spin-off from the holders of a majority of its outstanding long term debt securities issued by its subsidiary Autoliv ASP, the Board approved certain amendments to the agreements governing these securities.  For additional details see Autoliv’s Form 8-K to be filed with the SEC on May 24, 2018. Additional Information Autoliv expects to mail the information statement to all stockholders (including holders of shares represented by Autoliv SDRs) entitled to receive the distribution of shares of Veoneer common stock. The information statement is an exhibit to Veoneer’s registration statement on Form 10 that has been filed with the U.S. Securities and Exchange Commission (SEC) that provides information about Veoneer and its business, including the risks of owning Veoneer common stock, and other details regarding the spin-off. In addition, a Swedish prospectus, which is prepared for the purpose of admitting the Veoneer SDRs to trading on Nasdaq Stockholm, will also be made public prior to the spin-off. The distribution remains subject to satisfaction of certain customary conditions, as described in the preliminary information statement filed as an exhibit to the Form 10, including the SEC having declared effective the Form 10 and the Swedish Financial Supervisory Authority approving the Swedish prospectus. Future Reporting for Autoliv and Veoneer Following the spin-off, Autoliv will report its Electronics’ business as discontinued operations for the second quarter of 2018 and still intends to publish its second quarter results on July 27, 2018. Veoneer intends to publish an earnings release for the second quarter on or around July 27, 2018. This information is information that Autoliv, Inc. is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the VP of Investor Relations set out below, at 17.00 CET on May 24, 2018. Inquiries  Media: Thomas Jönsson, Corporate Communications. Tel +46 (0)8 587 206 27 Investors & Analysts, Anders Trapp, Investor Relations, Tel +46 (0)8 587 206 71 About Autoliv Autoliv, Inc. is the worldwide leader in automotive safety systems, and through its subsidiaries develops and manufactures automotive safety systems for all major automotive manufacturers in the world. Together with its joint ventures, Autoliv has more than 72,000 employees in 27 countries. In addition, the Company has 23 technical centers in nine countries around the world, with 19 test tracks, more than any other automotive safety supplier. Sales in 2017 amounted to about US $10.4 billion. The Company’s shares are listed on the New York Stock Exchange (NYSE: ALV) and its Swedish Depository Receipts on Nasdaq Stockholm (ALIVsdb). For more information about Autoliv, please visit our company website at www.autoliv.com. Safe Harbor Statement This release contains statements that are not historical facts but rather forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those that address activities, events or developments that Autoliv, Inc. or its management believes or anticipates may occur in the future, including those related to the completion and timing of the spin-off and distribution, including the satisfaction of the conditions to the distribution and the receipt of all required regulatory approvals, and the expected performance of Autoliv and Veoneer following completion of the spin-off. All forward-looking statements are based upon our current expectations, various assumptions and/or data available from third parties. Our expectations and assumptions are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties and other factors which may cause actual future results, performance or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements. Numerous risks, uncertainties and other factors may cause actual results to differ materially from those set out in the forward-looking statements, including general economic conditions and fluctuations in the global automotive market. For any forward-looking statements contained in this or any other document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we assume no obligation to update publicly or revise any forward-looking statements in light of new information or future events, except as required by law. 

Autoliv announces agreement with Cevian regarding Veoneer

Autoliv announced today that its board of directors has approved the completion of the previously announced spin-off of Veoneer into an independent publicly traded company. It also announced additional individuals that are expected to serve on the board of directors of Veoneer effective as of the completion of the spin-off, including Jonas Synnergren a partner of Cevian Capital. Pursuant to the agreement with Cevian, Autoliv and Veoneer agreed to take action for Veoneer to appoint Mr. Synnergren to Veoneer’s board following the spin-off of Veoneer and nominate him or another designee of Cevian at future annual meetings of Veoneer, subject to the terms and conditions of the agreement, including Cevian maintaining an at least 8% ownership position in the common stock of Autoliv as of the spin-off and Veoneer thereafter. Cevian has agreed to customary standstill and voting commitments under the agreement, including not acquiring more than 19.9% of the common stock of Veoneer. The full agreement with Cevian will be filed by Autoliv on a Current Report on Form 8-K with the Securities and Exchange Commission. This information is information that Autoliv, Inc. is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the VP of Investor Relations set out below, at 17.01 CET on May 24, 2018. Inquiries  Media: Thomas Jönsson, Corporate Communications. Tel +46 (0)8 587 206 27 Investors & Analysts: Anders Trapp, Investor Relations, Tel +46 (0)8 587 206 71 About Autoliv Autoliv, Inc. is the worldwide leader in automotive safety systems, and through its subsidiaries develops and manufactures automotive safety systems for all major automotive manufacturers in the world. Together with its joint ventures, Autoliv has more than 72,000 employees in 27 countries. In addition, the Company has 23 technical centers in nine countries around the world, with 19 test tracks, more than any other automotive safety supplier. Sales in 2017 amounted to about US $10.4 billion. The Company’s shares are listed on the New York Stock Exchange (NYSE: ALV) and its Swedish Depository Receipts on Nasdaq Stockholm (ALIVsdb). For more information about Autoliv, please visit our company website at www.autoliv.com. Safe Harbor Statement This release contains statements that are not historical facts but rather forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those that address activities, events or developments that Autoliv, Inc. or its management believes or anticipates may occur in the future, including those related to the completion and timing of the spin-off and distribution, including the satisfaction of the conditions to the distribution and the receipt of all required regulatory approvals, and the expected performance of Autoliv and Veoneer following completion of the spin-off. All forward-looking statements are based upon our current expectations, various assumptions and/or data available from third parties. Our expectations and assumptions are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties and other factors which may cause actual future results, performance or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements. Numerous risks, uncertainties and other factors may cause actual results to differ materially from those set out in the forward-looking statements, including general economic conditions and fluctuations in the global automotive market. For any forward-looking statements contained in this or any other document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we assume no obligation to update publicly or revise any forward-looking statements in light of new information or future events, except as required by law. 

Neste to acquire the share majority of the Dutch animal fat trader IH Demeter B.V.

Neste Corporation, Press Release, 25 May 2018 at 9 am (EET) Neste, a producer of renewable fuels from waste and residues, and IH Demeter B.V., a trader of animal fats and proteins, have agreed that Neste acquires sole control and 51 % of the shares of IH Demeter B.V., making Neste the controlling shareholder. The current owners shall remain as co-owners. The transaction is awaiting for and is subject to regulatory approval. “This is an important step for Neste in our strategy of building a global waste and residue raw material platform to secure raw material availability and competitiveness. We are very happy that the owners of IH Demeter B.V. accepted our offer and trust us to develop the business further,” says Kaisa Hietala, Executive Vice President of Renewable Products business area of Neste. “IH Demeter B.V. has a long history, and a solid track record of cooperating with Neste. With an efficient European-wide logistical setup, the company is well positioned to serve Neste in delivering future raw material volumes to our renewable product refineries,” continues Hietala. “We are proud of our raw material sourcing know-how and our capability of managing logistics of animal fats and proteins. The company has a long and successful history in operating as a family owned business. Now, we are happy to join Neste to further build up our business and secure future growth,” says Floris Ebeli of IH Demeter B.V. The sale and purchase agreement has been signed and parties have agreed that the purchase price will not be disclosed. The new company is planned to be called Neste Demeter B.V.. Neste Corporation Kaisa LipponenDirector, Corporate Communications More information: Kaisa Hietala, Executive Vice President, Renewable Products business area, Neste, tel. +358 10 458 4128 Floris Ebeli, Owner, IH Demeter B.V., tel. +31 6 53115202 Neste in brief Neste (NESTE, Nasdaq Helsinki) creates sustainable solutions for transport, business, and consumer needs. Our wide range of renewable products enable our customers to reduce climate emissions. We are the world's largest producer of renewable diesel refined from waste and residues, introducing renewable solutions also to the aviation and plastics industries. We are also a technologically advanced refiner of high-quality oil products. We want to be a reliable partner with widely valued expertise, research, and sustainable operations. In 2017, Neste's revenue stood at EUR 13.2 billion. In 2018, Neste placed 2nd on the Global 100 list of the most sustainable companies in the world. Read more: neste.com  IH Demeter B.V. in brief Founded in 1924, Demeter has become a large trader of animal fats and proteins. Currently, Demeter’s network covers some 150 rendering facilities throughout Europe, from which it acquires animal fats and proteins and transports them to their own storage facilities. Read more: http://demeter.nl/  

Jan Carlson appointed Honorary Doctor at Linköping University

Jan Carlson holds a MSc in Physics and Electrical Engineering from the Technical faculty at Linköping University and he is appointed Technology Honorary Doctorate for his achievements in Swedish industrial technical research and development. “I feel humble and deeply honored,” said Jan Carlson when appointed. “My background as an engineer from Linköping gave the best possible conditions for a successful career. I have had the fortune to spend most of my career at the forefront of electronics. It has always been a dynamic field – and today, when software companies enter the automotive industry, it is set under transformation becoming more interesting than ever before.” During Jan Carlson’s time as Chairman, President and CEO of Autoliv, Inc. the company has become an important player within traffic safety, within the areas of electronics, computer vision and other advanced sensor systems, which has included close cooperation with Linköping University all the way from undergraduate courses to research.   The Honorary Doctor Jan Carlson will hold a guest lecture about traffic safety and autonomous driving Friday May 25 at 11.00 in Ada Lovelace, B-huset, Campus Valla. Inquiries: Thomas Jönsson, Group Vice President Communications. Tel +46 (0)8 587 206 27 About Autoliv Autoliv, Inc. is the worldwide leader in automotive safety systems, and through its subsidiaries develops and manufactures automotive safety systems for all major automotive manufacturers in the world. Together with its joint ventures, Autoliv has more than 72,000 employees in 27 countries. In addition, the Company has 23 technical centers in nine countries around the world, with 19 test tracks, more than any other automotive safety supplier. Sales in 2017 amounted to about US $10.4 billion. The Company's shares are listed on the New York Stock Exchange (NYSE: ALV) and its Swedish Depository Receipts on Nasdaq Stockholm (ALIV sdb). For more information about Autoliv, please visit our company website at www.autoliv.com.  

TALKPOOL INTERIM REPORT JANUARY – MARCH 2018

JAN 1st – MAR 31st   · Net sales amounted to EUR 6 116 thousand (3 455), a 77 percent increase · EBITDA of EUR 507 thousand (-130) and EBITDA margin of 8.3 percent (-3.7) · EBIT of EUR 400 thousand (-147) and EBIT margin of 6.5 percent (-4.3) · Profit after tax of EUR 153 thousand (-188) · Operating cash flow amounted to EUR 993 thousand (10) JANUARY- MARCH HIGHLIGHTS · Financially the strongest quarter in Talkpool’s history · Revenue and profit overperforming the path set for 2021 · LCC Pakistan fully consolidated into the group for the first time · Germany, Tanzania and Haiti exceed expectations · Saudi Arabian Market entry and signature of first strategic customer contracts · Blockchain management consortium JoorsChain founded by Talkpool and Joors CEO COMMENTSQ1 2018 was the start of a new phase in Talkpool’s history. During the first 15 years Talkpool built a worldwide reputation as a professional and efficient communication network services company, which laid a solid foundation for future growth. Four years ago, Talkpool installed some of the first dedicated IoT networks in the world. It then became clear that IoT would be the future of Talkpool and that we needed the right financial capacity to leverage on our head start in IoT and become a major player in this business. Step one in our new strategy was to go public through an IPO on Nasdaq First North. The raised capital has been used to acquire profitable niche companies in Network Services to develop IoT products and solutions. The cash generated by the network services business will be used to acquire IoT companies and ramp up own IoT development. We have executed on this strategy and thereby more than doubled Talkpool’s monthly revenue and, in spite of all investments, we have improved our profit margins significantly. We have exceeded the growth expectations for the first two years and we are well ahead of schedule.The first quarter is normally the financially weakest quarter of the year, but Q1 2018 was the strongest in Talkpool’s history. This did not come as a surprise as Pakistan was fully consolidated into the group for the first time and the implementation of our strategy started to pay off. Some key markets did however exceed our expectations thanks to additional customer orders and the group as a whole clearly overperformed compared to the budget.In Q1 the trend of increasing customer demand for connecting larger volumes of things to the internet continued and as the existing availability of IoT-networks does not meet the market demand, Talkpool started exploring the possibility of taking the matter into its own hands and secure a faster roll out of LoRa-networks in the Nordic countries. Together with a few partners Talkpool initiated a Nordic IoT Network operator that will build and operate a LoRa network but also cooperate with other network operators to consolidate and extend the network coverage. Once a nationwide coverage is in place this will enable us to supply our IoT-solutions nationwide and to transform towards the final phase of our strategy - to sell IoT solutions as a service instead of as a product. Our continued focus will be on solutions for smart buildings measuring and controlling the indoor environment quality, which already has attracted interest from several real-estate owners as well as construction companies guaranteeing the construction quality and insurance companies granting liability insurances.Talkpool’s strategy of partnering with high quality sensor manufacturers both as assembly and sales channels, continued to show results in Q1. Among other partnerships Talkpool and Norautron AB entered into a strategic cooperation regarding the production and industrialization of Talkpool's new generation of Internet-of-Things (IoT) Sensors and Modems. The sensors support the LoRa wireless technology, which is on the rise. The first series has been produced and tested with good results and is scheduled to be launched before mid 2018.LCC Pakistan’s good relations and positive track record in the Middle East opened growth opportunities in the region. Talkpool entered the Saudi Arabian market in January as we expect large volumes of consulting and IoT orders to turn Saudi into one of Talkpool’s largest and most profitable markets. Initially Talkpool concentrates its efforts in Saudi on providing consulting services before increasingly focusing on IoT. Saudi Arabia is planning substantial investments in Internet of Things and the Saudi Vision 2030 includes smart city projects in which Talkpool is already involved.Talkpool also broke new technical ground as it co-founded a consortium called “JoorsChain” together with Joors and TrueChain to develop a blockchain platform to support telecom operators, media and ad-tech in transforming the mobile internet advertising industry. The fundamental idea is to create a modern ecosystem for managing micro-transactions involving several different parties in an easy, efficient and transparent way. There are several potential future applications, but the initial focus is on advertising management for mobile users and publishers. Blockchain technology complements our IoT strategy where we use our network and security expertise. Blockchain technology adds a new dimension to internet as it makes it possible to cut out expensive middle-men and improve security and transparency for all kinds of internet transactions.We continued to gain ground in Managed Services and Green Energy in several regions. We are implementing our own Pakistan-developed Remote Energy Management IoT solution ECHOTECH to manage client sites in Haiti. The IoT solution helps Talkpool and its customer Digicel to supervise the radio sites in the Operation & Maintenance project as well as control and reduce fuel consumption. This shows how well Talkpool's innovative solutions, local engineering skills and strong customer relationships begin to work together to deliver smart solutions as a service.Q2 2018In Q2 the IoT Network company Nordic IoT was launched and phase one of the network roll out is already in progress. The network will provide coverage in the regions of Stockholm, Gothenburg, Malmoe/Lund and Uppsala. Subsequent phases will provide coverage across Sweden, Norway and Denmark. Talkpool also formally incorporated the company JoorsChain AG in Switzerland as a management company for technical solutions and ownership of Intellectual Property based on blockchain technology.As clients ordered more work than Talkpool can finance, the board started evaluating additional financing methods such as bond, mezzanine and loans. Talkpool’s board is committed to minimise dilution going forward after having carried out several share issues in the part years.At the beginning of April Talkpool and the IVL Svenska Miljöinstitutet were awarded the ITSM initiative price 2018 for the environmental supervision project “Luft och Vatten med Internet of Things” in Gothenburg.Erik Strömstedt, CEO This information is inside information that Talkpool AG is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 09:30 CET on May 25, 2018. FOR FURTHER INFORMATION, PLEASE CONTACT:Erik Strömstedt, CEO Telephone: +41 79 790 60 40 erik.stromstedt@talkpool.com Hanna Rubensson, CFO   Telephone: +46 73 140 48 40 hanna.rubensson@talkpool.com TALKPOOLGäuggelistrasse 7      Telephone: +41 81 250 20 20CH-7000 Chur            Mail: info@talkpool.comSwitzerland                Web: www.talkpool.com THIS IS TALKPOOLTalkpool builds, maintains and improves telecommunication networks globally. Through its cutting-edge technical expertise, long experience and agile business model, Talkpool offers global telecom vendors and operators high-quality services on short notice no matter the location. Moreover, Talkpool is one of few companies with complete solutions and contracts in place in the emerging IoT-market.

Gaming Corps newly appointed CEO Mike Doyle comments

I am confident that I can be instrumental in turning Gaming Corps around and helping to develop it into the innovative, creative and profitable gaming company it has the potential to become. I have extensive production and business negotiation experience and my career has always been defined by both relentless work ethic and high integrity. I would not be involved if I did not sincerely believe that I can make a large and positive impact on this company and its shareholders.  I also guarantee that I will work hard to ensure that the company will not be managed in the way it has been by the departing CEO and the previous board - nor will the company be financed to the same extent through external parties. The money that we both have and raise will be directed towards sound business opportunities that have been vetted by a rigorous diligence process. To that end we believe that primary shareholders must be given the opportunity to supply such capital and to enjoy the benefit of that investment.  I see a strategic direction for gaming Corps where the company continues to reduce financial risk by outsourcing work-for-hire projects to Redfly Studio in Austin. In parallel we will seek to create lasting value through a combination of wholly owned IP based projects, innovative creative partnerships and licensed game development. I have already identified a number of projects which suit this strategy and it is precisely those opportunities that led me to join Gaming Corps in the capacity of CEO.  You can contact me at ir@gamingcorps.com. If possible, write in English. I will also be attending the AGM in Stockholm on Thursday May 31st, 2018 and look forward to seeing some of you there in person.  Mike Doyle CEO, Gaming Corps AB  General questions:Email: info@gamingcorps.com  IR- och PR related questions:Email: ir@gamingcorps.com   About Gaming Corps AB: Gaming Corps develops computer games based on their own IP’s and well-known international brands. The Company's shares are traded on Nasdaq First North under the ticker GCOR. The company's Certified Advisor is Remium Nordic AB.

Anders Holmgren leaves Cherry, effective immediately

Morten Klein, chairman of the board of Cherry AB commented: “Anders Holmgren has made valuable contributions as CEO of Cherry, but he is unable to perform his duties while facing accusations of severe insider trading. The board of directors has today decided to terminate his employment as CEO. In connection therewith, Anders Holmgren will also leave his assignments as board member in Cherry’s subsidiaries. As previously announced, Gunnar Lind is acting CEO and will remain in this position to ascertain that the group develops according to plan until a permanent CEO is appointed.” Gunnar Lind was CEO of Cherry AB between 2006 and 2011 and is currently member of the board and chairman of the Cherry Audit Committee. As announced in a press release in the afternoon of 24 May 2018, the Stockholm District Court on the same day detained Anders Holmgren on reasonable grounds suspected for severe insider trading. Cherry was on 22 May 2018, informed that the Swedish Economic Crime Authority had initiated an investigation of Anders Holmgren (please see press release dated 22 May 2018) and a prosecutor requested the court to detain him on 23 May 2018 (please see press release dated 23 May 2018).For further information, please contact:Morten Klein, Chairman of Cherry AB, tel: +47 913 22 222, morten@kleingroup.noAnders Antonsson, IR & Communications tel: +46 709 994 970, anders.antonsson@cherry.se This information is information that Cherry AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above on 25 May 2018, at 12:15 noon CET.  CHERRY IN BRIEF Cherry is a Swedish innovating and fast-growing company with operations in gaming, entertainment and media. The company was established in 1963 and today operates through five diversified business areas: Online Gaming, Game Development, Online Marketing, Gaming Technology, and Restaurant Casino. The objective is to grow organically in combination with strategic acquisitions of fast-growing companies. Cherry employs some 1,400 people and has about 6,700 shareholders. The company’s class B share is listed on the Nasdaq Stockholm exchange, Mid Cap segment. More information is available at www.cherry.se

Nordic Nanovector updates on Clinical Trial Applications for Archer-1 and PARADIGME Trials in Norway

Oslo, Norway, 25 May 2018 Nordic Nanovector ASA (OSE: NANO) has received feedback from the Regional Committees for Medical and Health Research Ethics (REK) in Norway with regard to the Clinical Trial Application (CTA) for the Archer-1 Phase 1b trial with Betalutin® (177Lu-satetraxetan-lilotomab) in combination with rituximab in second-line follicular lymphoma patients. Feedback from REK has been received following a review of the CTA for Archer-1, which took place on 26 April. The company and the lead investigator for the trial, Dr Arne Kolstad, senior consultant in medical oncology and radiotherapy at Oslo University Hospital Radiumhospitalet, are continuing discussions with REK towards gaining approval to start the study as soon as possible. Nordic Nanovector is targeting dosing of the first patient in the second half of 2018. The CTA for the PARADIGME Phase 2b trial was also reviewed by REK on 26 April and its decision is still pending. Both CTAs have already been approved by the Norwegian Medicines Agency (NoMA). PARADIGME is a global, randomised Phase 2b clinical trial comparing two promising Betalutin® dosing regimens in patients with third-line follicular lymphoma who are refractory to anti-CD20 immunotherapy (including rituximab), a population with a high unmet medical need. As of 5 April 2018, PARADIGME was open for enrolment in 13 clinical sites in 6 countries.  -End- For further information, please contact: IR enquiries Malene Brondberg, VP Investor Relations and Corporate Communications Cell: +44 7561 431 762 Email: ir@nordicnanovector.com International Media Enquiries Mark Swallow/David Dible/Isabelle Andrews (Citigate Dewe Rogerson) Tel: +44 207 638 9571 Email: nordicnanovector@citigatedewerogerson.com About Nordic Nanovector Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37-targeting antibody-radionuclide-conjugate designed to advance the treatment of non-Hodgkin's lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be worth nearly USD 20 billion by 2024. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets. Further information about the Company can be found at www.nordicnanovector.com

Ahlsell issues bond loan totalling MSEK 750

Ahlsell AB (publ) has today finalised a first issue of an unsecured bond with a total amount of MSEK 750 and a tenor of four years. This within the framework in the recently established MTN Programme. The bond loan carries a floating interest rate of three months STIBOR +2.00%. The interest for the issue was very high and the transaction was oversubscribed. The proceeds will be used to refinance parts of existing debt and for general business purposes. Ahlsell will apply for the new bond to be listed on Nasdaq Stockholm's Corporate Bond List. DNB and SEB have been financial advisors in connection with the bond issue. For further information please contact:Karin Larsson, Head of IR and external communications+46 8 685 59 24, karin.larsson@ahlsell.se Filip Berggren, Group Treasurer+46 8 685 70 14, filip.berggren@ahlsell.se Kennet Göransson, CFO+46 8 685 7040, kennet.goransson@ahlsell.se Ahlsell is the Nordic region’s leading distributor of installation products, tools and supplies for installers, construction companies, facility managers, industrial and power companies and the public sector. The unique customer offer covers more than one million individual products and solutions. The Group has a turnover of over SEK 28 billion and about 97 percent of revenue is generated in the three main markets of Sweden, Norway and Finland. With about 5,600 employees, more than 230 branches and three central warehouses, we constantly fulfil our customer promise: Ahlsell makes it easier to be professional! Press release, May 25, 2018